+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

List of PDF Full Texts available from EurekaMag Chapter 35975

Chapter 35975 contains a list of PDF Full Texts available from EurekaMag.





Pittman, D.L.; Schimenti, K.J.; Hanneman, W.H.; Schimenti, J.C., 1999:
Transgenic and mutational analyses of meiotic recombination in mice

Karasuyama, H.; Yonekawa, H.; Taya, C.; Matsuoka, K., 2000:
Transgenic animal allergy models and methods for their use

Nilsson, L.; Potter, H.; Arendash, G.W., 2004:
Transgenic animal and methods

Soreq, H.; Zakut, H.; Shani, M., 2000:
Transgenic animal assay system for anti-cholinesterase substances

Michaeli, Tamar, 2004:
Transgenic animal having a disrupted PDE7A gene and uses thereof

Van Der Putten, Petrus Herman Maria, 2003:
Transgenic animal model for neurodegenerative disorders

Grant, S.R.; Olson, E.N., 2001:
Transgenic animal models for cardiac hypertrophy and methods of use thereof

Bader, M., 2000:
Transgenic animal models for neuropharmacology

Soeller, W.C.; Carty, M.D.; Kreutter, D.K., 2001:
Transgenic animal models for type II diabetes mellitus

Arbatova, J.; Alhonen, L.; Kalda, A.; Zharkovsky, A.; Jolkkonen, J.; Reeben, M., 2001:
Transgenic animal models in studies of biochemical pathways of progressive myoclonus epilepsy

Gonzalez, Frank, J., 2002:
Transgenic animal models in toxicology studies

Toth, Miklos, 1999:
Transgenic animal models of epilepsy

Ward, K.A., 2002:
Transgenic animal technology turns 21 but is it ready for adult responsibilities?

Kieffer, B.; Matthes, H.W.D.; Simonin, F.H.rve; Dierich, A.; Lemeur, M., 2003:
Transgenic animal whose expression of the opiate receptors is modified

Von Euler, G.; Aase, K.; Betsholtz, C.; Eriksson, U.; Pekny, M.; Gebre Medhin, S.; Li, X., 2001:
Transgenic animal with recombinant vascular endothelial growth factor B and uses thereof

Xu, T.; Tao, W.; Wang, W.; Zhang, S.; Yu, W., 2003:
Transgenic animals and lats genes

Mirochnitchenko, O.; Inouye, M., 1999:
Transgenic animals and related aspects

Watt, F.M.; Carroll, J.M., 2001:
Transgenic animals as model of psoriasis

Feitelson, M.; Siracusa, L., 2000:
Transgenic animals capable of replicating hepatitis viruses and mimicking chronic hepatitis infection in humans

Cemal, C.; Huxley, C.; Mcguigan, A.; Chamberlain, S., 1999:
Transgenic animals carrying pathological alleles at the MJD1 locus exhibit a mild and slowly progressive cerebellar deficit

Kaslin, E.; Luyten, M.; Zerwes, H.G.nter, 2003:
Transgenic animals for studying regulation of genes

Merino, A.R.mirez; Caballero, M.A.gel Vidal; Moral, A.M.B.avo; Noval, J.L.is Jorcano, 2000:
Transgenic animals for the determination of agents which stimulate or repress epidermal hyperproliferation and hair growth

Sturchler-Pierrat, C.; Sommer, B., 1999:
Transgenic animals in Alzheimer's disease research

Brodmerkel, C.M.; Vaddi, K., 2003:
Transgenic animals in inflammatory disease models

Gachet, C.; Hechler, B.; Leon, C.; Cazenave, J.P.; Lanza, F., 2004:
Transgenic animals in primary hemostasis and thrombosis

Narumiya, S., 2004:
Transgenic animals of enzymes and receptors in prostanoid synthesis and actions; phenotypes and implications in drug development

Wasylyk, B.; Tocque, B.; Alkhalaf, M., 2000:
Transgenic animals overexpressing MDM2

Winston, R.M.L.; Hovatta, O.; Morgan, D.; Osian, O.; Readhead, C.W., 2000:
Transgenic animals produced after transduction of spermatogonia in situ and in natural mating

Gordon, K.; Groet, S.; Hennighausen, L.; Westphal, H., 2004:
Transgenic animals secreting desired proteins into milk

Fang, S.; Steinmetz, R.; Vogelveid, C.; Pescovitz, O.H., 1999:
Transgenic animals that produce the novel peptide, growth hormone releasing hormone-related peptide overexpress stem cell factor

Kalopissis, A.D.; Chambaz, J., 2000:
Transgenic animals with altered high-density lipoprotein composition and functions

Flachowsky, H.; Szankowski, I.; Fischer, T.C.; Richter, K.; Peil, A.; Höfer, M.; Dörschel, C.; Schmoock, S.; Gau, A.E.; Halbwirth, H.; Hanke, M-Viola., 2010:
Transgenic apple plants overexpressing the Lc gene of maize show an altered growth habit and increased resistance to apple scab and fire blight

Kotoda, N.; Iwanami, H.; Ishiguro, M.; Takahashi, S.; Soejima, J.; Kempin, S.; Yanofsky, M.; Wada, M., 2003:
Transgenic apple that overexpresses APETALA1, a floral meristem identity gene of Arabidopsis, is early flowering and sets fruit

Dubova, J.; Hermanova, K.; Brzobohaty, B., 1999:
Transgenic approach in pollen development study

Quan, Y.; Minocha, S.C.; Minocha, R., 2001:
Transgenic approach to study the interaction of polyamine and ethylene metabolism in plants

Kojima, N.; Obata, K., 1999:
Transgenic approaches for the study of kindling

Crestani, F., 2002:
Transgenic approaches to anxiety disorders and their pharmacotherapy Focus on GABA receptors

Boelck, B.; Brixius, K.; Frank, K.F.; Kranias, E.G.; Schwinger, R.H.G., 2002:
Transgenic approaches to define the functional role of FKBP12 in human myocardium

Sato, Y.; Luo, W.; Chu, G.; Zhou, Z.; Kadambi, V.J.; Kranias, E.G., 1999:
Transgenic approaches to elucidate the physiological significance of phospholamban phosphorylation sites under beta-adrenergic stimulation

Toth, M.; Tecott, L., 1999:
Transgenic approaches to epilepsy

Sommer, B.; Sturchler-Pierrat, C.; Abramowski, D.; Wiederhold, K.H.; Calhoun, M.; Jucker, M.; Kelly, P.; Staufenbiel, M., 2000:
Transgenic approaches to model Alzheimer's disease

Kerr, D.E.; Wells, K.D.; Wall, R.J., 2001:
Transgenic approaches to prevent bovine mastitis

Graham, K.E.; Low, M.J., 2000:
Transgenic approaches to study developmental expression and regulation of the gonadotropin genes

Tennant, R.; Haseman, J.; Stoll, R.E., 2001:
Transgenic assays and the identification of carcinogens

Cho, M.J.; Choi, H.W.; Bregitzer, P.; Zhang, S.; Lemaux, P.G., 2002:
Transgenic barley and chromosomal variation

Wong, J.H.; Ren, P.H.ien; Cai, N.; Cho, M.J.; Lemaux, P.G.; Buchanan, B.B., 2000:
Transgenic barley grain over-expressing wheat thioredoxin h shows improved germination properties

Chan, A.W.S.; Chong, K-Yu.; Schatten, G., 2002:
Transgenic bovine embryo selection using green fluorescent protein

Deboer, H.A.; Strijker, R.; Heyneker, H.L.; Platenburg, G.; Lee, S.H.; Pieper, F.; Krimpenfort, P.J.A., 2000:
Transgenic bovines and milk from transgenic bovines

Punja, Z.K.; Chen, W.P.; Yip, R., 2003:
Transgenic carrots expressing a thaumatin-like protein display enhanced tolerance to several fungal pathogens

Takatsu, Y.; Nishizawa, Y.; Hibi, T.; Akutsu, K., 1999:
Transgenic chrysanthemum Kitamura expressing a rice chitinase gene shows enhanced resistance to gray mold

Lee, S.Y.; Han, B.H.; Yoo, H.J.; Shin, H.K.; Mok, I.G.; Woo, J.G.; Suh, E.J.; Lim, Y.P., 2003:
Transgenic chrysanthemum with ls like gene expresses branchlessness habit

Bordignon, V.; Keystone, R.; Lazaris, A.; Keefer, C.; Smith, L.C., 2001:
Transgenic cloned calves derived from in vitro-transfected somatic cells using telophase- and metaphase-enucleated host oocytes

Dickneite, G.; Metzner, H.; Zettlmeissl, G.; Grundmann, U.; Lathe, R.; Smith, A.; Li, M., 2001:
Transgenic coagulation factor XIII defective animal and its use for testing wound healing and bleeding

Echelard, Y.; Groen, W.; Destrempes, M.M.; Ohlrichs, C.; Williams, J.L.; Ziomek, C.A.; Faber, D.; Meade, H.M.; Behboodi, E., 2000:
Transgenic cow production from microinjection into in vivo-derived embryos

Tsaftaris, A.S.; Polidoros, A.N.; Karavangeli, M.; Nianiou Obeidat, I.; Madesis, P.; Goudoula, C., 2000:
Transgenic crops Recent developments and prospects

Caimi, Perry, G., 2002:
Transgenic crops accumulating fructose polymers and methods for their production

Willis, J.; Sharma, G.C.; Zipf, A., 2003:
Transgenic crops suitable for small southeastern farms

Shi, D.J.; Shao, N.; Ran, L.; Li, Y.; Zhang, P.P.; Liu, F.L.; Luol, N.; Dai, W.; Ning, Y.; Peng, G.H.; Xu, X.D.; Shang, Z.D.; Ye, X.; Kang, R.J.; Zhang, H.; Dou, L.H.; Ouyang, Y.X.; Zhang, H.X., 2001:
Transgenic cyanobacteria as photosynthetic factories producing medicines

Scheele, J.S.; Zemojtel, T.; Duchniewicz, M., 2003:
Transgenic disruption of the gene of the small GTP-binding protein Rap1A in mice-evidence for expression of two murine isoforms closely related to Rap1A

Peng, C.F.; Miao, W.; Deguzman, A.; Ardati, A.; Della Penna, K.; Tremp, G.; Zilberstein, A.; Kitsis, R.N., 2002:
Transgenic dominant negative inhibition of Caspase-9 markedly decreases infarct size and improves cardiac function following ischemia-reperfusion

Chen, L.; Auh, C.K.oon; Dowling, P.; Bell, J.; Lehmann, D.; Wang, Z.Y., 2004:
Transgenic down-regulation of caffeic acid O-methyltransferase led to improved digestibility in tall fescue

Liefeldt, L.; Kramer, S.; Kreutz, R.; Peters, H.; Neumayer, H.H.; Paul, M., 2002:
Transgenic endothelin overexpression in rats Effects of age, gender and ACE-inhibition on renal parameters

Sher, L.B.; Woitge, H.W.; Harrison, J.R.; Adams, D.J.; Kream, B.E., 2002:
Transgenic expression of 11beta-hydroxysteroid dehydrogenase in osteoblasts reveals an anabolic role for endogenous glucocorticoids in bone

Imahashi, K.; Schneider, M.D.; Steenbergen, C.; Murphy, E., 2003:
Transgenic expression of Bcl-2 modulates energy metabolism and prevents cytosolic acidification during ischemia and reduces ischemia-reperfusion injury

Chitnis, T.; Abdallah, K.A.; Issazadeh, S.; Anil, C.; Wells, A.D.; Turka, L.A.; Sayegh, M.H.; Khoury, S.J., 1999:
Transgenic expression of Bcl-xL in T cells enhances susceptibility to EAE

Riazi, M.A.; Buchwald, M., 2001 :
Transgenic expression of CECR1 results in developmental abnormalities similar to features of cat eye syndrome

Upchurch, R.G.; Rose, M.S.; Callahan, T.M., 1999:
Transgenic expression of CFP enhances cercosporin resistance in a sensitive fungus

Epstein, J.A.an; Li, J.; Gitler, A.; Parada, L.; Zhu, Y., 2000:
Transgenic expression of Cre recombinase in neural crest cells allows for fate mapping of cardiac neural crest in the developing mouse embryo and for tissue specific gene inactivation

Fallas, J.L.; Tobin, H.M.; Lou, O.; Guo, D.; Sant'angelo, D.B.; Denzin, L.K., 2003:
Transgenic expression of HLA-DO in mouse dendritic cells diminishes MHC class II antigen presentation

Song, A.; Winer, S.; Pascari, P.; Kubiak, V.; Ellis, J.; Dosch, M., 2001:
Transgenic expression of ICA69 protects NOD mice from diabetes but not from insulitis and TH1 bias

Agarwal, R.K.; Viley, A.; Silver, P.; Grajewski, R.; Kronenberg, M.; Murray, P.; Rutschman, R.; Chan, C.C.ao; Caspi, R., 2004:
Transgenic expression of IL-10 targeted to macrophages protects from induction of Experimental Autoimmune Uveitis

Xu, H.; Wawrousek, E.F.; Redmond, T.M.chael; Nickerson, J.M.; Wiggert, B.; Chan, C.C.ao; Caspi, R.R., 1999:
Transgenic expression of IRBP induces a tolerance to the retinal antigen and reduces the susceptibility to experimental autoimmune uveoretinitis

Elhofy, A.; Karpus, W.J., 2001:
Transgenic expression of MCP-1 in the CNS inhibits EAE through decreased expression of IL-12Rbeta2

Zhao, S.; Ash, J.D.; Srinivasan, Y.; Overbeek, P.A., 1999:
Transgenic expression of TGFbeta1 in the lens inhibits retinal angiogenesis and results in retinal degeneration

Muhitch, M.J.; Mccormick, S.P.; Alexander, N.J.; Hohn, T.M., 2000:
Transgenic expression of TRI101 or PDR5 genes increases the resistance of tobacco plants to the Fusarium trichothecene 4,15-diacetoxyscirpenol

You, X.; Mungrue, I.N.; Afroze, T.; Husain, M., 1999:
Transgenic expression of a dominant negative c-Myb in arterial smooth muscle cells of mice reduces intimal-medial thickening following carotid artery injury

Murphy, A.M.; Georgakopoulos, D.; Kogler, H.; Kass, D.A.; Van Eyk, J.E.; Marban, E., 1999:
Transgenic expression of a truncated mutant of cardiac troponin I recapitulates myocardial stunning

Howland, D.S.; She, Y.; Kulik, J.; Culpepper, C.; Degennaro, L.J.; Khawaja, X.; Rosenzweig Lipson, S.; Marquis, K.; Dohlman, H.G.; Cockett, M.I.; Young, K.H., 2000:
Transgenic expression of an RGS-resistant Gqalpha mutant in rat brain

Waldner, H.P.; Whitters, M.; Collins, M.; Kuchroo, V.K., 1999:
Transgenic expression of autoreactive TCR overcomes self tolerance and induces autoimmunity in resistant mice

Buck, S.H.; Patel, J.R.; Muthuchamy, M.; Wieczorek, D.F.; Moss, R.L., 1999:
Transgenic expression of beta-tropomyosin in murine heart increases Ca2+ sensitivity of isometric tension and slows cross-bridge kinetics

Klug, D.B.; Crouch, E.; Carter, C.; Coghlan, L.; Conti, C.J.; Richie, E.R., 1999:
Transgenic expression of cyclin D1 in cortical thymic epithelial precursors enhances thymic epithelial and T cell development

Klein, R.D.; Bol, D.K.; Fischer, S.M., 2001:
Transgenic expression of cyclooxygenase-2 under control of the keratin 14 promoter leads to prostatic neoplasia

Sytwu, H.K.ng; Sung, J.; Hsieh, S.L.ang, 2004:
Transgenic expression of decoy receptor 3 protects islets from autoimmune and chemical-induced destruction in non-obese diabetic mice a novel approach toward islet transplantation

Kos, L.; Ittah, A.; Kalaiselvi, K., 2002:
Transgenic expression of endothelin receptor B rescues coat color spotting in piebald lethal mice

Sundaram, S.; Rathinasabapathi, B., 2010:
Transgenic expression of fern Pteris vittata glutaredoxin PvGrx5 in Arabidopsis thaliana increases plant tolerance to high temperature stress and reduces oxidative damage to proteins

Young, W.S.IIi; Iacangelo, A.; Luo, X.Z.J.; King, C.; Duncan, K.; Ginns, E.I., 1999:
Transgenic expression of green fluorescent protein and human oxytocin neurophysin in mouse oxytocin neurons

Zhang, P.X.; Loomis, R.; Flavell, R.; Fuleihan, R.L., 2000:
Transgenic expression of human CD40 ligand partially corrects CD40 ligand expression in knockout mice

Tschoepe, C.; Escher, F.; Spillmann, F.; Rehfeld, U.; Hauke, D.; Mochmann, C.; Reissfelder, C.; Koch, M.; Bader, M.; Walther, T.; Noutsias, M.; Vetter, R., 2000:
Transgenic expression of human kallikrein prevents altered left ventricular function, the decline in sarcoplasmic reticulum calcium pump activity and the rise in cardiac collagen content in diabetic rats

Tschoepe, C.; Vetter, R.; Wendorf, M.; Koch, M.; Spillmann, F.; Hauke, D.; Schultheiss, H.P.; Bader, M.; Walther, T., 2000:
Transgenic expression of human kallikrein prevents haemodynamic alterations and decline in sarcoplasmic reticulum calcium pump activity in diabetic rats

Vetter, R.; Spillmann, F.; Rehfeld, U.; Reissfelder, C.; Bader, M.; Schultheiss, H.P.; Paul, M.; Tschoepe, C., 2000:
Transgenic expression of human kallikrein prevents sarcoplasmic reticular calcium ion transport dysfunction in diabetic rat heart

Tschope, C.; Escher, F.; Spillmann, F.; Walther, T.; Bader, M.; Schultheiss, H.P.; Noutsias, M., 2002:
Transgenic expression of kallikrein prevents from diabetic cardiomyopathy by inhibition of ICAM-1 induction and infiltration

Noutsias, M.; Escher, F.; Spillmann, F.; Bader, M.; Tschoepe, C., 2001:
Transgenic expression of kallikrein prevents left ventricular dysfunction and inhibits endothelial induction of ICAM-1 and intramyocardial LFA-1/Mac-1+ infiltration in streptozotocin-induced diabetic cardiopathy in rats

Nathan, J.D.; Romac, J.M.J.; Peng, R.Y.; Peyton, M.; Macdonald, R.J.; Liddle, R.A., 2002:
Transgenic expression of monitor peptide in mice ameliorates secretagogue-induced pancreatitis

Rajavashisth, T.B.; Kumar, A.; Lee, G.; Doherty, T.; Uzui, H.; Tripathi, P.; Xu, J.; Neyer, J.; Chen, S.; Espinoza, C.; Zong, X.H.a; Dai, X.M.ng; Shah, P., 2003:
Transgenic expression of the cell surface isoform of CSF-1 reverses atheroprotective effects of CSF-1-deficiency in apolipoprotein E knockout mice

Stav, R.; Hendelman, A.; Buxdorf, K.; Arazi, T., 2010:
Transgenic expression of tomato bushy stunt virus silencing suppressor P19 via the pOp/LhG4 transactivation system induces viral-like symptoms in tomato

Wright, J.R.; Pohajdak, B., 2000:
Transgenic fish and a method of harvesting islet cells therefrom

Devlin, Robert, H., 1999:
Transgenic fish and vectors therefor

Winn, Richard, N., 1999:
Transgenic fish as models for mutation analyses

Cooper, R.K.; Enright, F.M., 1999:
Transgenic fish capable of expressing exogenous lytic peptides

Cornelissen, B.J.C.; Melchers, L.S.oerd; Meulenhoff, E.J.S.; Van Roekel, J.S.C.; Sela Buurlage, M.B.atrix; Vloemans, A.A.eida; Woloshuk, C.P.ter; Bol, J.F.rdinand; Linthorst, H.J.M., 2000 :
Transgenic fungal resistant plants expressing chitinase and glucanase, process for obtaining, and recombinant polynucleotides for uses therein

Norelli, J.L.; Borejsza Wysocka, E.E.; Reynoird, J.P.; Aldwinckle, H.S., 1999:
Transgenic gala apple expressing attacin E has increased field resistance to Erwinia amylovora

Tomioka, M.; Hahn Jun, L.; Fujii, K.; Tsubuki, S.; Watanabe, K.; Iwata, N.; Saido, T.C., 2001:
Transgenic generation of N-truncated Abeta bearing pyroglutamate induces calpain activation in the brain

Yang, X.B., 2000:
Transgenic glyphosate-resistant soybean and root disease

Shireen, K.F.; Pace, R.D.; Prakash, C.S.; Egnin, M., 1999:
Transgenic high-protein sweetpotatoes Their effects on protein quality and lipid metabolism

Kosorukov, V.S.; Antipova, T.A.; Prokofiev, M.I.; Ernst, L.K., 2000:
Transgenic house fly Musca domestica with neomycin resistance

Spencer, L.T.rry; Tobias, C.C.; Moen, G.C.; Brantly, M.L., 2000:
Transgenic human A1-antitrypsin administered by nebulization augments anti-protease protection and provides anti-inflammatory effects in the lower respiratory tract of patients with A1-antitrypsin deficiency

Catranis, C.M.; Manion, P.D.; Powell, W.A., 2000:
Transgenic hybrid poplar demonstrating in vitro pathogen resistance associated with in vivo expression of an antimicrobial peptide

Bailey, L.M.; Harvey, J.S.; Archer, G.E.B.; Rees, R.W.; Lynch, A.M., 2000:
Transgenic in vivo gene mutation assays Studies on a battery of clastogens with various mechanisms of genotoxicity

Montgomery, D.E.; Chandra, M.; Huang, Q.Q.; Jin, J.P.; Solaro, R.J.hn, 1999 :
Transgenic incorporation of chicken fast skeletal TnT into cardiac myofilaments blunts the PKC-induced depression of maximal tension

Mori, H., 2002:
Transgenic insects. Expressing green fluorescent protein-silk fibroin light chain fusion protein in transgenic silkworms

Zhukova, E.; Lu, Y.C.; Sternini, C.; Rozengurt, E., 2003:
Transgenic insulin production in the gastric G cells A model for gene therapy of diabetes

Schreiber, J.R.; Greenspan, N.S.; Threadgill, D.S.; Magnuson, T., 2000:
Transgenic knockout animals lacking IgG3

Seshadri, T.; Li, P.; Allen, H.; Banerjee, S.; Paskind, M., 2000:
Transgenic knockout mouse having functionally disrupted interleukin-1beta converting enzyme gene

Okubara, P.A.; Anderson, O.D.; Blechl, A.E.; Hohn, T.M., 1999:
Transgenic lines of Triticum aestivum carrying genes for candidate anti-Fusarium proteins

Wheeler, M.B., 2002:
Transgenic livestock Promise fulfilled

Koziel, M.; Desai, N.; Pace, G.M.; Suttie, J.; Carozzi, N.; Boyce, C.; Dawson, J.L.; Dunder, E.; Wright, M.; Launis, K.; Rothstein, S.J.; Lewis, K.; Warren, G.; Evola, S., 2004:
Transgenic maize seed and method for controlling insect pests

Allan, A.M.; Engel, S.R.; Lyons, C.R., 2001:
Transgenic mammal having 5-HT3 transgene overexpression in the CMS

Lubon, H.; Drohan, W.N.; Velander, W.H., 1999:
Transgenic mammals expressing human coagulation factor VIII

Wu, H.; Liu, X.; Lodish, H.F.; Giebel, L.B.; Ross, M.J.; Matthews, D., 2002:
Transgenic mammals lacking expression of erythropoietin or of erythropoietin receptor, transgenic mammals expressing chimeric erythropoietin receptors, constructs for producing the transgenic mammals and uses therefor

Lightfoot, D.A.; Mungur, R.; Ameziane, R.; Berhard, K.; Glass, A.D.M., 2000:
Transgenic manipulation of C and N metabolism Stretching GMO equivalence

Liu, Y.; Dilkes, B.P.; Dante, R.A.; Grafi, G.; Kretzschmar, E.; Leiva Neto, J.T.; Zhang, C.; Larkins, B.A., 2000:
Transgenic manipulation of cell cycle regulatory genes in maize endosperm

Kinoshita, Masato, 2003:
Transgenic medaka with brilliant fluorescence in skeletal muscle

Tomes, D.T.; Miller, P.D.; Bensen, R.J., 1999:
Transgenic methods and compositions for producing parthenocarpic fruits and vegetables

Tharaux, P.L.; Coffman, T.M., 2001:
Transgenic mice as a tool to study the renin-angiotensin system

Junien, C.; Seznec, H.; Lia, A.S.; Agbulut, O.; Duros, C.; Fouquet, C.; Radvany, H.; Gourdon, G., 1999:
Transgenic mice carrying the human DM region A model for CTG repeat intergenerational and somatic instability analysis of the CTG repeat amplification influence in transgenic mice

Seznec, H.; Savouret, C.; Agbulut, O.; Ourth, L.; Duros, C.; Tabti, N.; Willer, J.C.; Hagege, A.; Butler Browne, G.; Junien, C.; Gourdon, G., 2000:
Transgenic mice carrying the human myotonic dystrophy region A model for CTG repeat instability and its pathophysiological consequences

Hollenbeck, B.K.; Priyadarsiny, P.; Defeo Jones, D.; Neeley, C.; Vessella, R.; June, E.W.lke; Hwang, C.; Rubin, M.; Sanda, M.G., 2002:
Transgenic mice co-expressing PSA and human HLA A humanized transgenic model for prostate cancer immunotherapy development

Allen, Keith, D., 2004:
Transgenic mice containing BMP gene disruptions

Brennan, Thomas, J., 2004:
Transgenic mice containing DEZ orphan receptor gene disruptions

Allen, Keith, D., 2004:
Transgenic mice containing NPY6-R neuropeptide receptor gene disruptions

Mctiernan, C.F.; Feldman, A.M.; Kubota, T.; Frye, C., 1999:
Transgenic mice containing a nucleic acid encoding tumor necrosis factor-alpha under the control of a cardiac specific regulatory region

Allen, Keith, D., 2004:
Transgenic mice containing intestinal alkaline phosphatase gene disruptions

Yokoyana, W.M.; Kim, S., 2003:
Transgenic mice deficient in natural killer cells

Sfakianos, J.P.; Febbraio, M.; Simantov, R.; Guy, E.; Silverstein, R.L., 2002:
Transgenic mice demonstrate a role for HRGP in regulating blood vessel homeostasis

Bonilla, D.L.; Fan, Y-Yi.; Chapkin, R.S.; McMurray, D.N., 2010:
Transgenic mice enriched in omega-3 fatty acids are more susceptible to pulmonary tuberculosis: impaired resistance to tuberculosis in fat-1 mice

Leviten, Michael, W., 2003:
Transgenic mice exhibiting increased susceptibility to seizures

Muja, N.; Lovas, G.; Romm, E.; Machleder, D.; Ranjan, M.; Hudson, L.D., 2002 :
Transgenic mice exhibiting oligodendrocyte-specific expression of a mutant protein tyrosine phosphatase epsilon

Quintero, J.E.; Ponomareva, L.V.; Kuhlman, S.J.; Wagner, P.G.; Mcmahon, D.G., 1999:
Transgenic mice express fos-driven GFP fluorescence in the suprachiasmatic nucleus

Ginsburg, D.; Cui, J., 2000:
Transgenic mice expressing APC resistant factor V

Hsiao, K.; Borchelt, D.R.; Sisodia, S.S., 2001:
Transgenic mice expressing APP mutant at amino acids 717, 721 and 722

Hsiao, K.; Borchelt, D.R.; Sisodia, S.S., 1999:
Transgenic mice expressing APP-Swedish mutation develop progressive neurologic disease

Duff, K.; Hardy, J., 1999:
Transgenic mice expressing APPK670N,M671L and a mutant presenilin transgenes

Golde, T.E.; Onstead, L.; Piper, S.; Murphy, M.P.; Das, P.; Yu, C.; Skipper, L.; Hardy, J.; Mcgowan, E., 2001:
Transgenic mice expressing BRI-Abeta fusion proteins selectively overexpress Abeta42 and other Abeta peptides

Jolicoeur, P.; Hanna, Z.; Kay, D.G., 2001:
Transgenic mice expressing HIV-1 in immune cells

Moustafa, M.E.; Carlson, B.A.; Kryukov, G.V.; Sun, Q.A.; Diamond, A.M.; Lee, B.J.e; Gladyshev, V.N.; Hatfield, D.L., 2001:
Transgenic mice expressing I6A mutant Sec tRNA Sec Selective inhibition of Sec tRNA Sec maturation and selenoprotein synthesis

Salavert, A.; Casellas, A.; Ayuso, E.; Agudo, J.; George, M.; Bosch, F., 2003:
Transgenic mice expressing IGF-II in beta-cells develop diabetes after streptozotocin treatment

Turner, S.D.; Tooze, R.M.; Alexander, D.R., 2002:
Transgenic mice expressing Nucleophosmin-Anaplastic Lymphoma Kinase A model of anaplastic large cell lymphoma?

Jat, P.S.; Kioussis, D.; Noble, M.D., 1999:
Transgenic mice expressing TSSV40 large T antigen

Tawa, P.; Xu, D.; Nicholson, D.; Xanthoudakis, S., 2000:
Transgenic mice expressing a caspase-3 sensitive GFT-FRET substrate in cortical and hippocampal neurons

Bernal Mizrachi, E.; Ohsugi, M.; Donelan, S.; Johnson, J.; Otani, K.; Polonsky, K.; Permutt, M., 2003:
Transgenic mice expressing a dominant negative Akt in beta cells have normal cell mass, impaired glucose tolerance, decreased insulin secretory responses, and enhanced susceptibility to fat feeding and streptozotocin -induced diabetes

Gorska, A.E.a; Bhowmick, N.A.; Jensen, R.A.; Moses, H.L., 2001:
Transgenic mice expressing a dominant-negative type II TGFbeta receptor in mammary epithelia spontaneously develop ductal carcinoma in situ

Burnett, S.H.le; Zhang, J.; Qualls, J.E.; Kaplan, A.; Cohen, D., 2003:
Transgenic mice expressing a fas-based suicide gene for conditional ablation of macrophages

Suga, Y.; Ogawa, H.; Bundman, D.; Roop, D., 1999:
Transgenic mice expressing a mutant form of loricrin exhibit an erythrokeratoderma similar to Vohwinkel syndrome

Devlin, C.; Kuriakose, G.; Koschinsky, M.; Tabas, I., 2001:
Transgenic mice expressing an apolipoprotein peptide that binds the cholesterol-activated lipoprotein receptor have an increase in early foam cell lesions

Deane, N.G.; Lee, H.; Price, R.; Washington, M.K.y; Thorgeirsson, S.; Beauchamp, R.D.niel, 2003:
Transgenic mice expressing both TGF-beta cyclin D1 transgenes in hepatocytes exhibit increased liver tumors

Andrae, J.; Halter, R.; Heske, C.; Paul, D.; Vogel, C.W.lhelm, 2000:
Transgenic mice expressing cobra venom factor

Kins, S.; Crameri, A.; Nitsch, R.M.; Goetz, J., 2000:
Transgenic mice expressing dominant negative mutant forms of the catalytic subunit C alpha of the protein phosphatase 2A

Lubischer, J.L.; Newman, C.S.; Thompson, W.J.; Krieg, P.A., 2000:
Transgenic mice expressing enhanced green fluorescent protein under the control of the S100beta promoter expression pattern in the CNS

Shimada, T.; Yoneya, T.; Hino, R.; Takeuchi, Y.; Fukumoto, S.; Yamashita, T., 2001:
Transgenic mice expressing fibroblast growth factor 23 demonstrate hypophosphatemia with low serum 1,25-dihydroxyvitamin D 2D and rickets/osteomalacia

Szalai, A.J.; Vancott, J.L.; Mcghee, J.R.; Benjamin, W.H.Jr; Volanakis, J.E., 1999:
Transgenic mice expressing human C-reactive protein are resistant to Salmonella typhimurium

Piechocki, M.P.; Ho, Y.S.ih; Wei, W.Z.n, 2001:
Transgenic mice expressing human ErbB-2 under whey acidic protein promoter exhibit immunological tolerance to E2

Bacich, D.J.; Harsch, K.M.; Heston, W.D.W., 2002:
Transgenic mice expressing human Prostate-Specific Membrane Antigen in their prostate A potential model for prostate cancer initiation, development and therapy

Flay, N.W.; Vertel, B.M.; Schneider, G.B.; King, D., 2000:
Transgenic mice expressing human growth hormone in erythroid cells have enhanced bone deposition

Selden, R.; Goodman, H., 2000:
Transgenic mice expressing human insulin

Mcneish, J.D.; Ahlijanian, M.K., 2004:
Transgenic mice expressing human p25

S.G.orge Hyslop, P.H.; Rommens, J.M.; Fraser, P.E., 2002:
Transgenic mice expressing human presenilin proteins

Merkel, M.; Kako, Y.; Melford, K.; Breslow, J.L.; Bensadoun, A.; Goldberg, I.J., 1999:
Transgenic mice expressing lipoprotein lipase with a mutation in the carboxyl-terminal heparin binding region have large amounts of inactive LpL in preheparin plasma

Ruchoux, M.M.gdeleine; Domenga, V.; Brulin, P.; Maciazek, J.; Limol, S.; Tournier Lasserve, E.; Joutel, A., 2002:
Transgenic mice expressing mutant Notch3 develop vascular alterations characteristic of CADASIL

Deng, H.X.; Fu, R.; Zhai, H.; Dal Canto, M.C.; Siddique, T., 2002:
Transgenic mice expressing mutant a-synuclein develop neurological disorder and pathology

Hsiao, K.; Borchelt, D.R.; Sisodia, S.S., 2003:
Transgenic mice expressing mutant human APP and forming congo red staining plaques

Shashidharan, P.; Brin, M.F.; Gujjari, P.; Sandu, D.; Olanow, C.W., 2001:
Transgenic mice expressing mutant torsin-A display abnormal hyperkintic motor function

Dailey, M.O.; Farnsworth, M.; Shey, M.; Blink, S.; Kansas, G.S.; Zhao, L., 2002:
Transgenic mice expressing non-cleavable L-selectin

Carter, E.L.; Tigelaar, R.E.; Longley, B.J., 1999:
Transgenic mice expressing stem cell factor in basal keratinocytes develop postinflammatory hyperpigmentation in response to irritant and allergic contactants

Choi, Tae Saeng, 2001:
Transgenic mice expressing the HIK-ras 4B chimeric gene

Hoffman, D.A.; Jerecic, J.; Sprengel, R.; Sakmann, B., 2000:
Transgenic mice expressing the NMDA receptor point mutation NR1 , specifically in the forebrain, show an increased NMDA current in EPSCs recorded at resting potential in expressing CA1 hippocampal neurons

Nagata, M.; Shum, L.; Takahashi, K.; Cho, A.; Kulkarni, A.B.; Slavkin, H.C.; Nuckolls, G.H., 1999:
Transgenic mice expressing the P253R mutation of FGFR2 in chondrocytes exhibit craniofacial dysmorphology similar to Apert syndrome

Rauer, M.; Schuppli, D.; Gotz, J.; Staeheli, P.; Hausmann, J., 2002:
Transgenic mice expressing the nucleoprotein of Borna disease virus in either neurons or astrocytes

Anneren, C.; Welsh, M., 2000:
Transgenic mice expressing the tyrosine kinase Gtk exhibit increased cytokine-induced beta-cell toxicity

Arcos Fajardo, M.; Launay, P.; Grossetete, B.; Torres, S.P.; Patey Mariaud, D.S.rre, N.; Lehuen, A.; Monteiro, R.C., 2000:
Transgenic mice for human Fcalpha receptor develop IgA nephropathy Critical role for soluble receptor-IgA complexes and macrophage infiltration

Monteiro, R.C.; Launay, P.; Arcos Fajardo, M.; Grossetete, B.; Gaudin, E.; Torres, S.T.; Beaudoin, L.; Lehuen, A., 2000:
Transgenic mice for human IgA Fc receptor develops IgA nephropathy Evidences for a pathogenic role of soluble receptor/IgA complexes

Sato, T.; Yamada, M.; Oyake, M.; Nakao, K.; Nakamura, K.; Katsuki, M.; Takahashi, H.; Tsuji, S., 1999:
Transgenic mice harboring a full-length human DRPLA gene with highly expanded CAG repeats exhibit severe disease phenotype

Beach, D.H.; Serrano, M.; Depinho, R.A., 1999:
Transgenic mice having modified cell-cycle regulation

Hwang, B.J.; Feldman, D.E.; Feller, M.B., 2000:
Transgenic mice lacking retinal waves during the first postnatal week fail to form eye-specific layers in the dLGN

Buttiglione, M.; Bizzoca, A.; Polizzi, A.; D.B.nedictis, L.; Virgintino, D.; Gennarini, G., 2000:
Transgenic mice misexpressing the mouse axonal glycoprotein F3/F11/contactin display a cerebellar phenotype

Hwang, D.Y.; Chae, K.R.; Kang, T.S.; Hwang, J.H.; Lim, C.H.; Kang, H.G.; Goo, J.S.; Lee, M.R.; Kim, B.J.; Lim, H.J.; Cho, J.S.; Kim, Y.K., 2001:
Transgenic mice model for Alzheimers Disease by transferring PS-2 gene

Segev, O.; Irina, C.; Zvi, N.; Yuri, S.; Madar Shapiro, L.; Yayon, A., 1999:
Transgenic mice model for human achondroplasia

Fisher, I.B.; Ostrowski, M.; Muthusamy, N., 2002:
Transgenic mice over-expressing a non-phosphorylatable Ets-2 transcription factor reveal an increase in thymocyte cell death

Szigeti, G.P.; Asai, K.; Kim, S.J.; Vatner, S.; Rasmusson, R.L.; Yatani, A., 2000:
Transgenic mice over-expressing cardiac Gsalpha develop QT prolongation and decreased transient outward K+ currents with slowed inactivation

Stern, D.M.; Schmidt, A.M.rie; Yan, S.D., 2003:
Transgenic mice over-expressing receptor for advanced glycation endproduct and mutant APP in brain and uses thereof

Harrell, A.V.; Caldwell, K.K.; Allan, A.M., 2001:
Transgenic mice over-expressing the 5-HT3 receptor have enhanced learning in latent inhibition and contextual fear conditioning paradigms

Byrne, F.R.; Whoriskey, J.S.; Sarmiento, U.; Senaldi, G.; Zhang, M.; Gaida, K.; Danilenko, D.; Yoshinaga, S.K., 2001 :
Transgenic mice over-expressing the B7 related protein-1 develop an intestinal pathology similar to human Crohns disease a new mouse model of inflammatory bowel disease

Morgan, T.; Rohrwasser, A.; Ward, K., 2000:
Transgenic mice over-expressing the angiotensinogen gene fail to expand their plasma volume during pregnancy

Kim, J.; Kim, H.J.ong; Park, S.Y.ung; Cederberg, A.; Nilsson, D.; Westergren, R.; Higashimori, T.; Choi, H.; Dong, J.; Kim, Y.J.ng; Enerback, S.; Shulman, G., 2003:
Transgenic mice overexpressing FOXC2 are protected from high fat diet-induced insulin resistance in skeletal muscle and liver

Ruberte, J.; Ayuso, E.; Navarro, M.; Carretero, A.; George, M.; Nacher, V.; Costa, C.; Casellas, A.; Harigot, V.; Bosch, F., 2002:
Transgenic mice overexpressing IGF-I in eye A new animal model to study diabetic eye disease

Haurigot, V.A.; Ruberte, J.; Ayuso, E.; Navarro, M.; Carretero, A.; George, M.; Nacher, V.; Costa, C.; Casellas, A.; Bosch, A.; Bosch, F., 2003:
Transgenic mice overexpressing IGF-I in the retina develop diabetic eye disease

Pot, C.; Simonen, M.; Schnell, L.; Stoeckle, S.; Fouad, K.; Schwab, M., 2001:
Transgenic mice overexpressing Nogo-A in the peripheral nervous system

Hashimoto, H.; Tomimoto, S.; Shintani, N.; Baba, A., 2003:
Transgenic mice overexpressing PACAP in pancreatic beta cells Acute and chronic effects on insulin/glucose homeostasis

Hassanain, H.H.; Sarker, K.D.; Parker Thornburg, J.; Flavahan, S.; Wang, T.; Morris, M.; Kolattukudy, P.; Strauch, A.R.; Flavahan, N.A.; Goldschmidt Clermont, P.J., 1999:
Transgenic mice overexpressing Rac within smooth muscle cells

Marchbank, T.; Cox, H.; Goodlad, R.; Giraud, A.S.; Moss, S.; Wright, N.A.; Playford, R.J., 1999:
Transgenic mice overexpressing TFF3 within the jejunum have an increased regional resistance to intestinal damage but no difference in cell migration or apoptosis

Fisher, I.B.; Ostrowski, M.; Muthusamy, N., 2001:
Transgenic mice overexpressing a non-phosphorylatable Ets-2 transcription factor reveal defective development of T cells in the thymus

Dillon, S.; Haugen, H.; Kim, K.; Bontadelli, K.; Cutler, D.; Mudri, S.; Bilsborough, J.; Waggie, K.; Ren, H.P.; Maurer, M.; Harder, B.; Rosenfeld Franklin, M.; Sprecher, C., 2003:
Transgenic mice overexpressing a novel cytokine develop a severe pruritic skin phenotype resembling atopic dermatitis

Huber, S.; Schramm, C.; Herz, U.; Protschka, M.; Burg, J.; Finotto, S.; Schmitt, E.; Galle, P.R.; Blessing, M., 2003:
Transgenic mice overexpressing active TGFbeta1 in T-cells show altered T-cell development and resistance towards the induction of asthma

Irby, R.B.; Jackson, R.J.; Pledger, W.J.ck; Yeatman, T.J., 2002:
Transgenic mice overexpressing c-Src in the liver develop hepatocellular carcinoma

Ohsugi, M.; Bernal Mizrachi, E.; Wen, W.; Donelan, S.; Welling, C.; Permutt, M., 2003:
Transgenic mice overexpressing calcineurin in pancreatic islet beta cells develop glucose intolerance associated with a marked reduction in insulin secretion and beta cell mass

Tallent, M.K.; Baratta, M.V.; D.L.cea, L.; Siggins, G.R., 2000:
Transgenic mice overexpressing cortistatin show a deficit in dentate gyrus long-term potentiation

Lo, A.C.; Ho, M.C.; Chung, S.K., 2000:
Transgenic mice overexpressing endothelin-1 in astrocytes display greater infarct size and more severe neurological deficit after transient focal cerebral ischemia

Higashimori, T.; Kim, H.J.ong; Coschigano, K.; Park, S.Y.ung; Choi, H.; Kopchick, J.; Shulman, G.; Kim, J., 2003:
Transgenic mice overexpressing growth hormone are insulin resistant due to decreased insulin-stimulated glucose uptake in skeletal muscle and adipose tissue

Christou, H.; Minamino, T.; Hsieh, C.M.ng; Liu, Y.; Lynch, L.; Mitsialis, S.A.ex; Perrella, M.A.; Kourembanas, S., 2000:
Transgenic mice overexpressing heme oxygenase-1 in the lung are protected from development of hypoxia-induced pulmonary hypertension Evidence of antiinflammatory effects of HO-1

Mullan, M.; Town, T.; Mori, T.; Pompl, P.; Delledonne, A.; Crawford, F.; Flavell, R.A.; Tan, J., 2001:
Transgenic mice overexpressing mutant APP but deficient for CD40L have reduced Alzheimer-like pathology

Arad, M.; Moskowitz, I.P.; Patel, V.V.; Ahmad, F.; Perez Atayde, A.R.; Sawyer, D.B.; Li, G.H.; Burgon, P.G.; Maguire, C.T.; Stapleton, D.; Schmitt, J.P.; Guo, X.X.; Berul, C.I.; Seidman, J.G.; Seidman, C., 2002:
Transgenic mice overexpressing mutant PRKAG2 recapitulate the human cardiomyopathy, characterized by ventricular hypertrophy and preexcitation

Franckhauser, S.; Munoz, S.; Ferre, T.; Bosch, F., 2003:
Transgenic mice overexpressing phosphoenolpyruvate carboxykinase in adipose tissue are more sensitive to diet-induced insulin resistance

D.C.om, R.; Van Haperen, R.; Van Gent, T.; Scheek, L.; Van Der Kamp, A.; Van Tol, A., 2000:
Transgenic mice overexpressing phospholipid transfer protein are less susceptible to diet-induced hypercholesterolemia

Duff, Karen, 2000:
Transgenic mice overexpressing presenilin cDNAs Phenotype and utility in the modeling of Alzheimers disease

Takahara, N.; Clermont, A.; Kagokawa, H.; Takahara, H.; Kurihara, H.; Bursell, S.; King, G.L., 1999:
Transgenic mice overexpressing protein kinase C beta isoform mimicked the early vascular changes of diabetes

Reddig, P.J.; Dreckschmidt, N.E.; Oberley, T.D.; Verma, A.K., 1999:
Transgenic mice overexpressing protein kinase Cdelta in the epidermis exhibit hyperproliferation and ulceration of the skin

Yasuda, H.; Mizuno, A.; Kannno, T.; Hoshi, M.; Shibata, O.; Yano, K.; Fujise, N.; Kinosaki, M.; Yamaguchi, K.; Tsuda, E.; Murakami, A.; Higashio, K., 2002:
Transgenic mice overexpressing soluble RANKL exhibit severe osteoporosis

Pirinen, E.; Virkamaki, A.; Heikkinen, S.; Janne, J.; Laakso, M., 2003:
Transgenic mice overexpressing spermidine/spermine N1-acetyltransferase are protected from high-fat diet induced obesity, glucose intolerance and insulin resistance

Kiviranta, R.; Morko, J.; Uusitalo, H.; Aro, H.T.; Rantakokko, J.; Vuorio, E., 2000:
Transgenic mice overexpressing the cathepsin K gene exhibit accelerated turnover of metaphyseal bone

Rubin, D.C.; Swietlicki, E.A.; Iordanov, H.; Fritsch, C.; Levin, M.S., 2002:
Transgenic mice overexpressing the immediate early gene PC4/TIS7 in the small bowel are growth retarded

Cooksey, R.C.; McClain, D.A., 2002:
Transgenic mice overexpressing the rate-limiting enzyme for hexosamine synthesis in skeletal muscle or adipose tissue exhibit total body insulin resistance

Cheah, A.Y.L.; Zaidi, S.H.E.; You, X.M.ng; Dawood, F.; Wen, W.H.; Husain, M.; Liu, P.; Rabinovitch, M., 1999:
Transgenic mice overexpressing the serine elastase inhibitor elafin and experimental myocardial infarct following coronary artery ligation

Zaidi, S.H.E.; You, X.M.ng; Husain, M.; Ciura, S.; O'blenes, S.; Rabinovitch, M., 1999:
Transgenic mice overexpressing the serine elastase inhibitor elafin are protected against carotid arterial injury

Ishihara, T.; Hong, M.; Zhang, B.; Trojanowski, J.Q.; Lee, V.M.Y., 2001:
Transgenic mice overexpressing the shortest human tau isoform develop a progressive tauopathy

Saarelainen, T.; Pussinen, R.; Koponen, E.; Alhonen, L.; Wong, G.; Sirviö, J.; Castrén, E., 2000 :
Transgenic mice overexpressing truncated trkB neurotrophin receptors in neurons have impaired long-term spatial memory but normal hippocampal LTP

Saarelainen, T.H.; Lukkarinen, J.A.; Koponen, S.; Grohn, O.H.; Jolkkonen, J.; Koponen, E.; Haapasalo, A.; Alhonen, L.; Wong, G.; Koistinaho, J.; Kauppinen, R.A.; Castren, E., 2000:
Transgenic mice overexpressing truncated trkB neurotrophin receptors show increased susceptibility to cortical injury after focal cerebral ischemia

Coleman, C.S.; Megosh, L.C.; O'brien, T.G.; Pegg, A.E., 2000:
Transgenic mice show increased expression of spermidine/spermine N1-acetyltransferase in papillomas produced in response to a two-stage initiation/promotion protocol

Eslin, D.E.; Zhang, C.; Samuels, K.J.; Gewirtz, J.E.; Cines, D.B.; Kowalska, A.M.; Poncz, M., 2003:
Transgenic mice studies demonstrate a role for platelet factor 4 in thrombosis Implications for heparin therapy

Gould, T.J.; Abel, T., 2000:
Transgenic mice that overexpress a constitutively active form of Gsalpha have disrupted prepulse inhibition

Koon, M.H.W.; Chung, S.S.M.; Chung, S.K., 2001:
Transgenic mice that overexpress endothelin-1 develop hypertension

Rich, B.E.; Stathopoulos Connell, J.; Liu, L.; Kupper, T.S., 2000:
Transgenic mice to probe the biology of dendritic cells

Skynner, M.J.; Drage, D.J.; Dean, W.L.; Turner, S.; Watt, D.J.; Allen, N.D., 1999:
Transgenic mice ubiquitously expressing human placental alkaline phosphatase An additional reporter gene for use in tandem with beta-galactosidase

Bonn, D., 1999:
Transgenic mice used to unravel physiological function of heparin

Yenari, M.A.; Lee, J.E.; Sun, G.H.; Giffard, R.G.; Steinberg, G.K., 1999:
Transgenic mice which overexpress HSP70 are protected against some but not all central nervous system insults

Albers, K.M.; Davis, B.M., 1999:
Transgenic mice which overexpress neurotrophin-3 and methods or use

Afdhal, N.H.; Masuzaki, H.; Turner, B.; Nasser, I.; Flier, J., 2002:
Transgenic mice with 11 beta-hydroxysteroid dehydrogenase type 1 overexpression in adipocytes develop fatty liver disease

Nagai, M.; Aoki, M.; Miyoshi, I.; Okamura, T.; Kato, M.; Kasai, N.; Itoyama, Y., 2000:
Transgenic mice with ALS-linked SOD1 mutant H46R

Kato, M.; Aoki, M.; Nagai, M.; Miyoshi, I.; Imanishi, T.; Kasai, N.; Itoyama, Y., 2001:
Transgenic mice with ALS-linked SOD1 mutant L84V

Edgemon, K.; Haluzik, M.; Cutler, D.A.; Zarnowski, M.J.; Gavrilova, O.; Londos, C.; Reitman, M.L., 2002:
Transgenic mice with Partial Lipodystrophy due to expression of Lamin A or C cDNA containing a Dunnigan-specific mutation

Evans, C.C.; Wolska, B.W.; Pena, J.R.; Muthuchamy, M.; Wieczorek, D.F.; Solaro, R.J., 1999:
Transgenic mice with a mutation of tropomyosin linked to familial hypertrophic cardiomyopathy show altered myocardial relaxation

Ranganathan, G.; Knoop Hensley, L.; Wells, B.; D.G.egorio, G.; Kern, P., 2003:
Transgenic mice with adipose specific expression of LPL lacking the proximal 3UTR demonstrate translational-up regulation of LPL

Hidalgo, J.; Florit, S.; Giralt, M.; Ferrer, B.; Keller, C.; Pilegaard, H., 2010:
Transgenic mice with astrocyte-targeted production of interleukin-6 are resistant to high-fat diet-induced increases in body weight and body fat

Engelhardt, S.; Hein, L.; Lohse, M.J., 1999:
Transgenic mice with cardiac specific overexpression of the beta1-adrenergic receptor

Vinge, L.E.; Von Lueder, T.; Bjornerheim, R.; Attramadal, H., 2003:
Transgenic mice with cardiac-specific inhibition of GRK3 display phenotype with cardiac hypertrophy and alpha1-adrenergic receptor hyper-responsiveness

Knollmann, B.C.; Trivedi, K.K.; Weissman, N.J.; Morad, M., 1999:
Transgenic mice with cardiomyopathy - An attractive model for drug development?

Soergel, D.G.; Stull, L.B.; Janssen, P.M.L.; Murphy, A.M., 2002:
Transgenic mice with constitutive phosphorylation of PKA sites of troponin I

Fukuchi, K.; Li, L.; Pham, D.; Oh, S.J.; Lindsey, J.R., 1999:
Transgenic mice with deposition of amyloid-beta protein in skeletal muscle Model of inclusion body myopathy

Serra, C.; Federici, M.; Buongiorno, A.; Senni, M.I.; Morelli, S.; Segratella, E.; Pascuccio, M.; Tiveron, C.; Mattei, E.; Tatangelo, L.; Lauro, R.; Molinaro, M.; Giaccari, A.; Bouché, M., 2003:
Transgenic mice with dominant negative PKC-theta in skeletal muscle: a new model of insulin resistance and obesity

Mueller, F.U.; Loser, K.; Neumann, J.; Schmitz, W., 2000:
Transgenic mice with heart-specific overexpression of the cAMP-response element modulator

Kim, J.K.; Fillmore, J.J.; Sunshine, M.J.an; Chen, Y.; Zong, H.; Littman, D.R.; Shulman, G.I., 2001:
Transgenic mice with inactivation of PKC-theta are protected from lipid-induced defects in insulin action and signaling in skeletal muscle

Fillmore, J.J.; Kim, J.K.; Zong, H.; Clapham, J.C.; Shulman, G.I., 2001:
Transgenic mice with muscle-specific overexpression of UCP3 are protected from high fat diet induced defects in insulin action in liver and muscle

Yan, S.; Zhang, H.P.; Battaglia, F.; Zhu, Y.; Stern, D.M.; Ramasamy, R.; Arancio, O., 2001:
Transgenic mice with neuronal overexpression of ABAD and mutant APP display impaired synaptic transmission and decreased brain ATP

Shimizu Hirota, R.; Sasamura, H.; Kuroda, M.; Kobayashi, E.; Hayashi, M.; Saruta, T., 2003:
Transgenic mice with over-expression of biglycan develop enhanced vascular proliferation and migration

Park, S.Y.ung; Spurlin, B.; Kim, H.J.ong; Higashimori, T.; Choi, H.; Kim, Y.J.ng; Noh, H.L.m; Thurmond, D.; Kim, J., 2003:
Transgenic mice with overexpression of syntaxin 4 have increased insulin sensitivity but mice with overexpression of Munc18c are insulin resistant in skeletal muscle

Harndahl, L.; Wierup, N.; Ahren, B.; Sundler, F.; Holst, L.S.enson, 2003:
Transgenic mice with reduced beta-cell cAMP levels develop severe diabetes when challenged with a high-fat diet

Eckhart, A.D.; Ozaki, T.; Koch, W.J., 2000:
Transgenic mice with vascular smooth muscle targeted overexpression of the betaadrenergic receptor kinase are a novel model of hypertension

Cobb, S.; Ceci, J.; Wood, T.; Deng, X.; Owlia, A.; Varro, A.; Singh, P., 2002:
Transgenic mice, over-expressing progastrin in the colon are highly susceptible to colon carcinogenesis in response to azoxymethene

Huisman, G.W.; Peoples, O.P.; Skraly, F.A., 2003:
Transgenic microbial polyhydroxyalkanoate producers

Port, J.D.vid; Bristow, M.R., 2001:
Transgenic model and treatment for heart disease

Leinwand, L.A.; Vikstrom, K.L., 2002 :
Transgenic model for heart failure

Murphy, A.M.; Georgakopoulos, D.; Kass, D.A.; Van Eyk, J.E.; Marban, E., 1999:
Transgenic model of myofilament dysfunction in myocardial stunning

Mankodi, A.K.; Logigian, E.L.; Orimo, S.; Callahan, L.; Thornton, C.A., 2000:
Transgenic model of myotonic dystrophy

Mackenzie, A.; Quinn, J.P., 2000:
Transgenic models for analysis of preprotachykinin-A gene expression

Kerr, D.E.; Wellnitz, O.; Mitra, A.; Wall, R.J., 2002:
Transgenic models for animal science research and application

Young, L.J.; Insel, T.R., 2001:
Transgenic models for oxytocin and vasopressin

Whitsett, J.A.; Glasser, S.W.; Tichelaar, J.W.; Perl, A.K.; Clark, J.C.; Wert, S.E., 2001:
Transgenic models for study of lung morphogenesis and repair: Parker B. Francis lecture

Niswender, C.M.; Mcknight, G.S., 2004:
Transgenic models for the study of protein kinase A-regulated signal transduction

Gustafsson, J.A., 2001:
Transgenic models in reproductive research

Gonzalez, F.J., 2002:
Transgenic models in xenobiotic metabolism and toxicology

Morris, R.G.M., 2002:
Transgenic models of Alzheimers disease Behavioural studies and the prospects of therapeutic immunization

Chapman, P.F.; Falinska, A., 2003:
Transgenic models of Alzheimers disease used for validation of novel drug targets

Wang, D.; Russell, J.L.; Johnson, D.G., 2000:
Transgenic models of E2F1 and E2F4 function

Garvey, S.M.; Christine, K.S.; Wetsel, W.C.; Rodriguiz, R.M.; Conde, C.B.; Kowaljow, V.; Stajich, J.M.; Gaskell, P.C.; Vance, J.M.; Pericak Vance, M.A.; Rosa, A.L.; Hauser, M.A., 2002:
Transgenic models of LGMD1A Expression of altered human myotilin results in a dominant-negative phenotype

Hashimoto, M.; Rockenstein, E.; Masliah, E., 2003:
Transgenic models of alpha-synuclein pathology: past, present, and future

Ohta, T.; Gray, T.A.; Limwongse, C.; Lamb, B.T.; Nicholls, R.D., 2000:
Transgenic models of imprinting, protein production, and phenotypic rescue in Prader-Willi syndrome

Duff, G.W.; Nicklin, M., 2002:
Transgenic models of inflammatory disease

Mackenzie, A.; Quinn, J.P., 2002:
Transgenic models to determine both expression and function of the human tachykinin genes in vivo

Denno, R.; Iwata, S.; Kawada, K.; Obama, K.; Kawai, Y.; Kanai, M.; Taki, Y.; Takabayashi, A., 2000:
Transgenic modulation of hepatic energy synthesis attenuates deteriorations of the mitochondrial permeability in peripheral blood lymphocytes after hepatectomy

Nasir, J., 2001:
Transgenic monkey raises hope for primate models of human diseases

Adams, T.R.; Anderson, P.C.; Daines, R.J.; Gordon Kamm, W.; Kausch, A.P.; Mann, M.T.; Orr, P.M.; Warner, D.C., 2001:
Transgenic monocots plants with increased glycine-betaine content

Schenk, Dale, B., 2004:
Transgenic mouse assay to determine the effect of Abeta antibodies and Abeta Fragments on alzheimers disease characteristics

Olson, Eric, N., 2002:
Transgenic mouse comprising a MEF2 binding site operatively linked to an indicator gene and methods of use

Schwarz, J.; Chen, C.K.ng; Simon, M.I.; Lester, H., 2004:
Transgenic mouse comprising a disruption in an RGS9 gene

Benson, M.D.; Murrell, J.; Farlow, M.; Ghetti, B., 2001:
Transgenic mouse expressing APP770-V717F

Nalbantoglu, J.; Julien, J.P.erre; Shapiro, M., 1999:
Transgenic mouse expressing C-100 app

Pulst, S.M.; Huynh, D.P., 2003:
Transgenic mouse expressing a polynucleotide encoding a human ataxin-2 polypeptide

Hardy, J.A.thony; Chartier Harlin, M.C.ristine; Goate, A.M.ry; Owen, M.J.hn; Mullan, M.J.hn, 2001:
Transgenic mouse expressing an APP-FAD DNA sequence

Sato, M.; Kobayashi, T.; Tada, N.; Shoji, M.; Kawarabayashi, T., 2000:
Transgenic mouse expressing an beta-Amyloid transgene

Sawada, Shinichiro, 2001:
Transgenic mouse expressing human fusin and human CD4

Vitek, M.P.; Dawson, H.N.; Loring, J.F., 2003:
Transgenic mouse expressing human tau gene

Pasinetti, Giulio, M., 2003:
Transgenic mouse expressing the human cyclooxygenase-2 gene and neuronal cell cultures derived therefrom

Boyer, A.; Dornan, S.; Daneau, I.; Lussier, J.G.; Silversides, D.W., 2001:
Transgenic mouse expression model for DMRT1 promoter

Nohmi, T., 2000:
Transgenic mouse gpt delta Development, recent progress and future directions

Zheng, H.; Chen, H.Y.; Trumbauer, M.E.; Van Der Ploeg, L.H.T.; Seabrook, G.; Sirinathsinghji, D., 2001:
Transgenic mouse having a disrupted amyloid precursor protein gene

Kohara, M.; Wakita, T.; Yonekawa, H.; Taya, C.; Saito, I., 2001:
Transgenic mouse hepatitis C virus model comprising a hepatitis C viral fragment

Davis, J.; Romanov, G.; Van Nostrand, W.E., 2001:
Transgenic mouse lines expressing neuronal or circulating platelet Dutch-type mutant AbetaPP

Lira, S.A.; Yang, T.Y.an, 2003:
Transgenic mouse model for Kaposis sarcoma

Grant, S.R.; Olson, E.N.; Molkentin, J.D., 2003:
Transgenic mouse model for cardiac hypertrophy and methods of use thereof

Abumrad, N.; Ibrahimi, A.; Picken, C.M., 2001:
Transgenic mouse model for fatty acid transport

Clarke, L.A.; Jirik, F., 1999:
Transgenic mouse model for iduronidase deficiency and methods of making and using same

Zhao, J.; Guzman, G.; Hernandez, O.; Diaz, Z.; Szczesna Cordary, D., 2004:
Transgenic mouse model for the E22K mutation in myosin regulatory light chain that causes Familial Hypertrophic Cardiomyopathy

Sidhu, J.; Gollob, M.J.; Yuan, R.; Wang, Z.; Appleton, G.O.; Li, Y.; Demayo, F.J.; Carling, D.; Khoury, D.S.; Roberts, R., 2003:
Transgenic mouse model of Wolff-Parkinson-White syndrome with inducible supraventricular tachycardia generated by expressing the human AMPK mutation Arg302Glu

Mucke, L.; Wyss Coray, T.; Masliah, E., 2001:
Transgenic mouse model of alzheimers disease and cerebral amyloid angiopathy

Yang, B.; Verkman, A.S., 2000:
Transgenic mouse model of autosomal recessive nephrogenic diabetes insipidus

Hui, C.C.ung; Dlugosz, A.A., 2004:
Transgenic mouse model of basal cell carcinoma

Xu, R.; Chi, L.; Ke, Y.; Luo, C.; Gozal, D.; Liu, R., 2003:
Transgenic mouse model of de novo motor neuron regeneration to replace degenerated motor neurons in ALS-like mice

Ding, H.; Roncari, L.; Shannon, P.; Macmaster, S.; Wu, X.; Lau, N.; Nagy, A.; Guha, A.; Gutmann, D., 2000:
Transgenic mouse model of malignant astrocytoma Astrocyte specific expression of activated Ras

Ding, H.; Macmaster, S.; Roncari, L.; Wu, X.; Lau, N.; Shannon, P.; Gutman, D.; Nagy, A.; Guha, A., 2000:
Transgenic mouse model of malignant astrocytoma Specific astrocyte specific expression of activated ras

Sindermann, J.; Babij, P.; March, K.L., 1999:
Transgenic mouse model of positive vessel remodeling and smooth muscle cell proliferation

Sindermann, J.; Babij, P.; March, K.L., 1999:
Transgenic mouse model of positive vessel remodelling and smooth muscle cell proliferation

Gordon, J.I.; Garabedian, E.M., 1999:
Transgenic mouse model of prostate cancer

Lee, H.J.; Gomi, H.; Iwata, N.; Watanabe, K.; Tomioka, M.; Hosoki, E.; Sekiguchi, M.; Maruyama, K.; Itohara, S.; Saido, T.C., 2000:
Transgenic mouse model that accumulates a senile human brain-specific pathological form of amyloid-beta peptide, Abeta3 -42

Lee, H.J.; Watanabe, K.; Sekiguchi, M.; Tsubuki, S.; Hosoki, E.; Maruyama, K.; Iwata, N.; Saido, T.C., 1999:
Transgenic mouse model that accumulates pyroglutamyl beta-amyloid peptide

Herzig, M.; Niedermeyer, J.; Cavallaro, U.; Novatchkova, M.; Perl, A.K.rina; Christofori, G., 2000:
Transgenic mouse models as a tool to study multistage tumorigenesis

Korth, C.; Kaneko, K.; Heye, N.; Scott, M.; Prusiner, S.B., 2000:
Transgenic mouse models for Creutzfeldt-Jakob disease

Gispert, S.; Cabin, D.; Auburger, G.; Orrison, B.M.; Bernard, D.J.; Nussbaum, R.L., 1999:
Transgenic mouse models for hereditary Parkinsons Disease

Wu, X.R.; Sun, T.T.en, 2001:
Transgenic mouse models for human bladder cancer

Nakashima, I.; Du, J.; Yokoyama, T.; Kawamoto, Y.; Ohkusu Tsukada, K.; Isobe, K.I.hi, 2003 :
Transgenic mouse models for immunosenescence

Falk, P.G.; Syder, A.J.; Guruge, J.L.; Engstrand, L.G.; Gordon, J.I., 2001:
Transgenic mouse models for studying the relationship between Helicobacter pylori infection and gastric cancer

Son, J.H.; Chun, H.S.; Peng, C.; Joh, T.H.; Baker, H.; Nessler, E.J.; Chen, J.S., 1999:
Transgenic mouse models for the spatiotemporal control of neurotrophin expression in SN dopaminergic neurons and striatum

Whitsett, J.A.; Korfhagen, T.R., 2000:
Transgenic mouse models for the study of growth factor signaling during lund morphogenesis

Brose, N.; Rettig, J., 2004:
Transgenic mouse models in the analysis of neurotransmitter release mechanisms

Duff, K.; Suleman, F., 2004:
Transgenic mouse models of Alzheimer's disease: how useful have they been for therapeutic development?

Bates, G.P.; Mangiarini, L.; Davies, S.W., 2000:
Transgenic mouse models of Huntingtons disease

Blaxall, B.C.; Koch, W.J., 2004:
Transgenic mouse models of cardiovascular function and disease

Singh, M.; Kumar, V., 2003:
Transgenic mouse models of hepatitis B virus-associated hepatocellular carcinoma

McCauley, L.K., 2001:
Transgenic mouse models of metabolic bone disease

Matusik, R.J.; Masumori, N.; Thomas, T.; Case, T.; Paul, M.; Kasper, S.; Shappell, S.B., 2001:
Transgenic mouse models of prostate cancer

Holmdahl, R.; Andersson, E.C.; Andersen, C.B.; Svejgaard, A.; Fugger, L., 1999:
Transgenic mouse models of rheumatoid arthritis

Tennant, Raymond, W., 2001:
Transgenic mouse models of toxicity and cancer

Palmen, J.A.; Calvisi, D.F.; Ladu, S.; Thorgeirsson, S.S., 2002:
Transgenic mouse models recapitulate genetic alterations of human human hepatocellular carcinoma

Timblin, C.; Robledo, R.; Rincon, M.; Cummins, A.; Pfeiffer, L.; Mossman, B., 2001:
Transgenic mouse models to determine the role of epidermal growth factor receptor in epithelial cell proliferation, apoptosis, and asbestosis

Rees, T.; Younkin, S.; Soreq, H.; Lockridge, O.; Brimijoin, W.S., 2000:
Transgenic mouse models to study interactions of brain acetylcholinesterase and amyloid beta

Hernández, Félix.; Lim, F.; Lucas, Jé.J.; Pérez-Martín, Cón.; Moreno, F.; Avila, Jús., 2002:
Transgenic mouse models with tau pathology to test therapeutic agents for Alzheimer's disease

Simmons, C.F.Jr; Bisbas, D.S., 2001:
Transgenic mouse strains exhibit flourescent visceral and vascular smooth muscle cell development

Kettenhofen, R.; Schwengberg, S.; Kolossov, E.; Ehlich, A.; Bohlen, H.; Kleber, M.; Messinger, H.; Hescheler, J.; Fleischmann, B.; Aulmann, W., 2002:
Transgenic murine embryonic stem cells as an in-vitro model for developmental toxicity An alternative to the gold standard

Leonard, Warren, J., 1999:
Transgenic murine model for XSCID

Tiwari, Suresh Chandra, 2003:
Transgenic mustard

Mizuno, T.M.; Yang, X.J.; Kelley, K.A.; Pasinetti, G.M.; Mobbs, C.V., 2001:
Transgenic neuronal expression of proopiomelanocortin reduces body weight and improves glucose tolerance in wild-type and leptin-deficient mice

Soreq, H.; Zakut, H.; Shani, M., 1999:
Transgenic non-human animal assay system for anti-cholinesterase substances

Lonberg, N.; Kay, R.M., 2001:
Transgenic non-human animals for producing heterologous antibodies

Littman, D.; Sawada, S.; Killeen, N., 1999:
Transgenic non-human animals having targeting endogenous lymphocyte transduction genes and cognate human transgenes

Houdebine, L.M.rie; Devinoy, E.; Thepot, D., 1999:
Transgenic non-human mammal comprising a rabbit WAP promoter

Houdebine, L.M.rie; Devinoy, E.; Thepot, D., 2001:
Transgenic non-human mammal comprising a rabbit WAP promoter, uses thereof, and a DNA construct comprising the rabbit WAP promoter

Hansson, L.; Stromqvist, M.; Bergstrom, S.; Hernell, O.; Tornell, J., 2001:
Transgenic non-human mammal expressing the DNA sequence encoding kappa casein mammary gland and milk

White, D.J.mes; Williams, A.F.ederick, 2002:
Transgenic non-human mammals expressing DNA sequences encoding homologous complement restriction factors of a discordant mammalian species

Prieto, P.A.; Kopchick, J.J.; Cummings, R.D.; Pierce, J.M.; Smith, D.F.; Moremen, K.W., 2001:
Transgenic non-human mammals expressing heterologous glycosyltransferase DNA sequences produce oligosaccharides and glycoproteins in their milk

Lubon, H.; Drohan, W.N.; Velander, W.H., 2001:
Transgenic non-human mammals expressing human coagulation factor VIII and von Willebrand factor

Hansson, Lennart, 2000:
Transgenic non-human mammals producing EC-SOD protein in their milk

Cummings, R.D.le; Kopchick, J.J.seph; Moremen, K.W.lson; Mukerji, P.; Pierce, J.M.chael; Prieto, P.A.tonio; Smith, D.F.etcher, 1999:
Transgenic non-human mammals producing oligosaccharides and glycoconjugates

Cordell, Barbara, 1999:
Transgenic non-human mice displaying the amyloid-forming pathology of alzheimers disease

Schatten, G., 2002:
Transgenic non-human primates Bridges spanning the biomedical gap between mouse disease models and humans?

Bujard, H.; Gossen, M.; Salfeld, J.G.; Voss, J.W., 2001:
Transgenic organisms having tetracycline-regulated transcriptional regulatory systems

Otani, M.; Shimada, T.; Mii, M., 2001:
Transgenic ornamental Ipomoea

D.C.estecker, M.P.; Bassity, C.M.; Nangle, S.; Factor, V.M.; Roberts, A.B.; Kopp, J.B., 1999:
Transgenic over-expression of Bone Morphogenetic Protein-7 in liver and kidney suggests a role in maintaining normal renal and hepatocyte function in the adult

Huang, W.Y.arn; Izumo, S., 1999:
Transgenic over-expression of a biological inert molecule can cause dilated cardiomyopathy A caveat in cardiac transgenic mice

Lai, C.C.ing; Hollander, J.; Belke, D.; Scott, B.; Dillmann, W.; Su, C.Y.an, 2004:
Transgenic overexpression of Constitutive Heat Shock Protein 70 Protects Against Ischemia/Reperfusion Injury

Boltax, J.; Bacani, C.J.seph; Svensson, E.C.; Huggins, G.S.encer, 2001:
Transgenic overexpression of FOG-2 produces myocardial fibrosis

Jan, F.; Kim, J.; Eckhart, A.D.; Koch, W.J., 2003:
Transgenic overexpression of GRK5 in vascular smooth muscle can lead to enhanced VSM migration and mitogenic signaling

Schulze, P.C.ristian; Fang, J.; Kassik, K.A.; Gannon, J.; Macgillivray, C.; Rosenthal, N., 2003:
Transgenic overexpression of IGF-1 inhibits skeletal muscle activation of the ubiquitin-proteasome pathway in chronic ventricular dysfunction

Eckstein, F.; Buerklein, D.; Fisch, T.; Priemel, M.; Wanke, R.; Hoeflich, A.; Amling, M.; Mohan, S.; Wolf, E., 2003:
Transgenic overexpression of IGFBP-2 produces sex- and site-specific inhibitory effects on GH-induced skeletal changes in mice

Hanson, J.C.; Bostick, M.K.; Campe, C.B.; Maher, J.J., 2002:
Transgenic overexpression of Interleukin-8/CXCL-8 protects mice from toxin-induced hepatic apoptosis

Philpot, B.D.; Weisberg, M.P.; Ramos, M.S.; Sawtell, N.B.; Tang, Y.P.; Tsien, J.Z.; Bear, M.F., 2001:
Transgenic overexpression of NR2B does not alter NMDA receptor current duration or synaptic plasticity in visual cortex

Schroeder, F.; Paraskeva, S.; Klein, G.; Schnasse, N.; Fiedler, B.; Lohmann, S.; Wollert, K.C., 2001:
Transgenic overexpression of PKG I augments the inhibitory effects of cyclic-GMP on L-type calcium channel activity in cardiac myocytes

Flagg, T.P.; Remedi, M.S.; Masia, R.; Mclerie, M.; Lopatin, A.; Nichols, C.G., 2004:
Transgenic overexpression of SUR1 in the heart exerts dominant negative effects on sarcolemmal KATP

Smith, K.M.; Thurston, G.; Suri, C.; Murphy, T.J.; Mcdonald, G.D.Y.ncopoulos And, D.M., 1999:
Transgenic overexpression of VEGF and angiopoietin-1 induce the proliferation of vessels of different size

James, J.; Zhang, S.; Osinska, H.; Klevitsky, R.; Hewett, T.; Sambe, A.; Robbins, J., 1999:
Transgenic overexpression of a mutation in murine cardiac troponin I results in cardiac hypertrophy and early lethality

Kaji, E.H.; Ryeom, S.; Wu, J.C.; Mckeon, F.D., 2001:
Transgenic overexpression of calcipressin 1 inhibits angiotensin II and thyroxine-induced cardiac hypertrophy

Monaco, M.H.; Bleck, G.T.; Cook, J.B.; Wheeler, M.B.; Donovan, S.M., 2000:
Transgenic overexpression of insulin-like growth factor-I in milk of swine using the bovine alpha-lactalbumin promoter and regulatory regions

Zhao, G.; Racadio, M.; Michalkiewicz, M., 2004:
Transgenic overexpression of neuropeptide Y ameliorates pressor effects of sinoaortic baroreceptor-denervation in conscious rats

Failinger, C.F.; Kan, H.; Jain, A.C.; Finkel, M.S., 2002:
Transgenic overexpression of neuropeptide Y in rats A novel cardiomyopathy model

Roos, K.P.; Jordan, M.C.; Lu, L.; Lu, Y.; Philipson, K.D.; Ross, R.S., 2000:
Transgenic overexpression of the Na+-Ca2+ exchanger results in postpartum hypertrophy and heart failure

Most, P.; Koch, W.J.; Loeffler, E.K.; Ehlermann, P.; Pleger, S.T.; Rockman, H.A.; Katus, H.A.; Remppis, A., 2002:
Transgenic overexpression of the cardiac EF-hand Ca2+ binding protein S100A1 A novel strategy to increase myocardial contractile performance

Hollander, J.M.; Martin, J.L.; Belke, D.D.; Scott, B.T.; Dillmann, W.H., 2003:
Transgenic overexpression of wild type hsp27 and a hsp27 nonphosphorylatable mutant protects against ischemia/reperfusion injury

Brodie, C.R.; Yin, J.C.P.; Clark, H.B.; Boland, L.M.; Orr, H.T., 2000:
Transgenic overexpression of wild-type CREB blocks endogenous CREB function

Brodie, C.R.; Yin, J.C.; Clark, H.B.; Boland, L.M.; Orr, H.T., 2000:
Transgenic overexpression of wild-type CREB inhibits CRE-responsive genes

Hanaoka, R.; Hosoya, T.; Hotta, Y.; Kamoto, H., 2001:
Transgenic overexpression of zebrafish gcmb induces ectopic expression of endothelin-1 and affects the pharyngeal cartilage formation

Bosch, F.; Fankchauser, S.; Casellas, A.; Otaegui, P.; Hidalgo, A.; Munoz, S.; Ferre, T.; Mas, A.; Riu, E., 2002:
Transgenic overexpression studies in obesity and diabetes

Krishna, G.; Urda, G.; Tefera, W.; Reindel, J., 2001:
Transgenic p53 knockout mice as an alternative model for carcinogen bioassay Results with cyclophosphamide

Schoenfelder, G.; Bohnemeier, H.; Neumerkel, M.; Labouvie, C.; Chahoud, I.; Paul, M., 2002:
Transgenic pS2 promoter-rats as a model for the investigation of transcriptional mechanisms in the regulation of TFF1 expression

Fermin, G.; Gonsalves, D., 2002:
Transgenic papaya A case of technology transfer to Venezuela

Logemann, J.; Jach, G.; Gornhardt, B.; Mundy, J.; Schell, J.; Eckes, P.; Chet, I., 2001:
Transgenic pathogen-resistant plant

Ozias Akins, P.; Yang, H.; Perry, E.; Akasaka, Y.; Niu, C.; Holbrook, C.; Lynch, R., 2002:
Transgenic peanut for preharvest aflatoxin reduction

Kuhlman, S.J.; Quintero, J.E.; Mcmahon, D.G., 1999:
Transgenic period 1 promoter drives rhythmic GFP gene expression in the mouse SCN

Nottle, M.B.; D'Apice, A.J.F.; Cowan, P.J.; Boquest, A.C.; Harrison, S.J.; Grupen, C.G., 2002:
Transgenic perspectives in xenotransplantation, 2001

Takahagi, Y.; Miyagawa, S.; Murakami, H.; Matsunami, K.; Fujimura, T.; Shigehisa, T.; Shirakura, R., 2003:
Transgenic pigs expressing both human decay-accelerating factor and N-acetylglucosaminyltransferase III

Beschorner, W.; Prather, R.; Sosa, C.; Thompson, S.C.; Schieber, T.; Yang, T., 2003:
Transgenic pigs expressing the suicide gene thymidine kinase in the liver

Golovan, S.P.; Meidinger, R.G.; Ajakaiye, A.; Cottrill, M.; Wiederkehr, M.Z.; Barney, D.; Plante, C.; Pollard, J.; Fan, M.Z.; Hayes, M.A.; Laursen, J.; Hjorth, J.P.; Hacker, R.R.; Phillips, J.P.; Forsberg, C.W., 2002:
Transgenic pigs producing salivary phytase Low phosphorus manure through enhanced digestion of organic phosphorus

Miyagawa, S.; Murakami, H.; Murase, A.; Nakai, R.; Koma, M.; Koyota, S.; Matsunami, K.; Takahagi, Y.; Fujimura, T.; Shigehisa, T.; Nagashima, H.; Shirakura, R.; Taniguchi, N., 2001:
Transgenic pigs with human N-acetylglucosaminyltransferase III

Zhang, Bao Hong, 2000:
Transgenic plant A new source of biodegradable plastics

Takaiwa, F.; Utsumi, S.; Katsube Tanaka, T., 2003:
Transgenic plant expressing soybean glycinin

Hood, E.E., 2003:
Transgenic plant-produced cellulases for biomass conversion

Chupeau, Y., 2003:
Transgenic plants: towards a more balanced diet?

Lee, L.; Berg, J.B.adley, 1999:
Transgenic plants and method for node segment transformation

Keller, W.A.; Fabijanski, S.F.; Arnison, P.G.; Hammerlindl, J.K.; Webb, S.R., 2004:
Transgenic plants and methods for production thereof

Rausch, Thomas, 2004:
Transgenic plants and plant cells comprising a reduced expression of invertase inhibitors

Austin Phillips, S.; Burgess, R.R.; German, T.L.; Ziegelhoffer, T., 1999:
Transgenic plants as an alternative source of lignocellulosic-degrading enzymes

Walmsley, A.M.; Kirk, D.D.; Mason, H.S.; Arntzen, C.J., 1999:
Transgenic plants as vectors for delivery of animal immunocontraceptive vaccines

D.B.th, M.; Ben Tahar, S.; Noel, M.; Perret, J., 2001:
Transgenic plants belonging to the species Cucumis melo

Silverman, R.H.; Mitra, A., 1999:
Transgenic plants co-expressing a functional human 2-5A system

Adang, M.J.; Murray, E.E., 2000:
Transgenic plants comprising a synthetic insecticidal crystal protein gene having a modified frequency of codon usage

Heard, J.; Broun, P.; Riechmann, J.L.is; Keddie, J.; Pineda, O.; Adam, L.; Samaha, R.; Zhang, J.; Yu, G.L.ang; Ratcliffe, O.; Pilgrim, M.; Jiang, C.Z.ong; Reuber, L., 2003:
Transgenic plants comprising polynucleotides encoding transcription factors that confer disease tolerance

Holton, Timothy Albert, 2000:
Transgenic plants exhibiting altered flower color and methods for producing same

Tricoli, D.M.; Carney, K.J.; Russell, P.F., 2000:
Transgenic plants exhibiting heterologous virus resistance

Boeshore, M.L.; Deng, R.Z.; Camey, K.J.; Reynolds, J.F.; Ruttencutter, G.E., 2000:
Transgenic plants expressing ACC oxidase genes

Boeshore, M.L.; Deng, R.Z.; Carney, K.J.; Ruttencutter, G.E.; Reynolds, J.F., 1999:
Transgenic plants expressing ACC synthase gene

Tricoli, D.M.; Carney, K.J.; Russell, P.F.; Quemada, H.D.; Mcmaster, R.J.; Reynolds, J.F.; Deng, R.Z., 2002:
Transgenic plants expressing DNA constructs containing a plurality of genes to impart virus resistance

Sheen, J.; Chiu, W.L.ng, 2003:
Transgenic plants expressing a dual-specificity MAPK phosphatase and uses thereof

Hein, M.B.; Hiatt, A., 2002:
Transgenic plants expressing assembled secretory antibodies

Sadowsky, M.J.; Wackett, L.P.; Vance, C.P.; Samac, D.A., 2002:
Transgenic plants expressing bacterial atrazine degrading gene AtzA

Broekaert, W.F.ans; Cammue, B.P.illippe Angelo; Rees, S.B.onwen; Vanderleyden, J., 1999 :
Transgenic plants expressing biocidal proteins

Lorito, M.; Zoina, A.; Scala, F., 2000:
Transgenic plants expressing genes from fungal antagonists

Baum, J.A.; Gilmer, A.J.len; Mettus, A.M.rie Light, 1999:
Transgenic plants expressing lepidopteran-active delta-endotoxins

Stout, J.T.; Luu, H.T.; Hanson, S.F.; Maxwell, D.P.; Ahlquist, P.G.; Gilbertson, R.L., 2001:
Transgenic plants expressing mutant geminivirus AC1 or C1 genes

Petell, J.K.; Merlo, D.J.; Herman, R.A.; Roberts, J.L.; Guo, L.; Schafer, B.W.; Sukhapinda, K.; Merlo, A.O.ens, 2003:
Transgenic plants expressing photorhabdus toxin

Tian, Yuying; Boyle, Stephen, M.; Pierson, William, F.; Cramer, Carole, 1999:
Transgenic plants for delivery of poultry vaccines against hemorrhagic enteritis

Holton, T.A.bert; Tanaka, Y., 1999:
Transgenic plants having altered anthocyann levels

Patton, D.A., 1999:
Transgenic plants having increased biotin content

Araya, A.; Mouras, A., 1999:
Transgenic plants including a transgene consisting of a hybrid nucleic acid sequence, comprising at least one unedited mitochondrial gene fragment from higher plants and process for producing them

Shoseyov, O.; Shani, Z.; Shpigel, E., 2001:
Transgenic plants of altered morphology

Poulsen, Peter, 2002:
Transgenic plants or algae expressing an AGP enzyme coupled to a transit peptide

Koops, A.J.rriaan; Sevenier, R.; Van Tunen, A.J.hannes; D.L.enheer, L., 2003:
Transgenic plants presenting a modified inulin producing profile

Londesborough, J.; Tunnela, O.; Holmstrom, K.O.e; Mantyla , E.; Welin, B.; Mandal, A.; Palva, T.E., 2000:
Transgenic plants producing trehalose

Braun, Carl Joseph, 2000:
Transgenic plants resistant to geminivirus infection

Bqczek Kwinta, R., 2001:
Transgenic plants resistant to oxidative stress in various environmental conditions

Coruzzi, G.M.; Brears, T., 1999:
Transgenic plants that exhibit enhanced nitrogen assimilation

Amasino, R.M.; Gan, S.; Noh, Y.S.n, 2002:
Transgenic plants with altered senescence characteristics

Heo, W.D.; Cho, M.J.; Song, P.S.on; Chung, C.H., 2001:
Transgenic plants with divergent SCaM5 gene to achieve multiple disease resistance

Pandey, G.K.mar; Reddy, V.S.va; Deswal, R.; Bhattacharya, A.; Sopory, S.K.mar, 2004:
Transgenic plants with enhanced chlorophyll content and salt tolerance

Dellapenna, D.; Shintani, D.K., 2003:
Transgenic plants with gamma-tocopherol methyltransferase

Wyatt, S.; Tsou, P.L.n; Robertson, D.; Boss, W., 2004 :
Transgenic plants with increased calcium stores

Libantova, J.; Bauer, M.; Bekesiova, I.; Moravcikova, J.; Mlynarova, L'udmila, 1999:
Transgenic potato plants expressing basic vacuolar glucanase from Nicotiana plumbaginifolia and acidic extracellular chitinase from cucumber

Trifonova, E.A.; Komarova, M.L.; Leonova, N.S.; Shcherban', A.B.; Kochetov, A.V.; Malinovskii, V.I.; Shumnyi, V.K., 2004:
Transgenic potato plants expressing the gene of secretory nuclease from Serratia marcescens

Backhausen, J.E.; Horton, P.; Scheibe, R., 2000:
Transgenic potato plants with altered leaf-ferredoxin expression The role of NADP-malate dehydrogenase in stabilizing the chloroplast redox state

During, K., 2000:
Transgenic potato tubers as a potent production system for recombinant antibodies

Hellwege, E.M.; Czapla, S.; Jahnke, A.; Willmitzer, L.; Heyer, A.G., 2000:
Transgenic potato tubers synthesize the full spectrum of inulin molecules naturally occurring in globe artichoke roots

Reggio, B.C.; James, A.N.; Green, H.L.; Gavin, W.G.; Behboodi, E.; Echelard, Y.; Godke, R.A., 2000:
Transgenic pregnancies resulting from nuclear transfer in the goat FSH-stimulated vs nonstimulated recipient cytoplasts

Couto, Dan, 2002:
Transgenic production

Knapp, J.E.; Brand, M.H., 2003:
Transgenic production of disease-resistant Impatiens wallerana

Fan, J.; Watanabe, T., 2003:
Transgenic rabbits as therapeutic protein bioreactors and human disease models

Shamburek, R.D.; Hoeg, J.M.; Duverger, N.; Houbebine, L.M.rie; Hoyt, R.F.Jr.; Wood, D.O.; Santamarina Fojo, S.; Brewer, H.B.yan, J., 1999:
Transgenic rabbits expressing both human apoA-I and LCAT have a protective lipoprotein profile with increased HDL and enhanced LDL catabolism

Fan, J.; Shimoyamada, H.; Challah, M.; Honda, K.; Watanabe, T., 1999:
Transgenic rabbits expressing human apolipoprotein develop enhanced atherosclerotic lesions in response to a cholesterol-rich diet

She, Y.; Howland, D.S.; Psaltis, G.; Devito, L.; Kulik, J.; Degennaro, L.J.; Cleveland, D., 2001:
Transgenic rat expressing human superoxide dismutase 1 G93A as a model for Amyotrophic lateral sclerosis

Reid, W.; Sadowska, M.; Denaro, F.; Rao, S.; Foulke, J.Jr; Hayes, N.; Fouts, T.; Lewis, G.; Kamin Lewis, R.; Ray, P.; Gallo, R.; Reitz, M.; Bryant, J., 2000:
Transgenic rat model for HIV-1 infection

Sato, K.; Taniyama, Y.; Sugawara, A.; Uruno, A.; Kudo, M.; Ito, S.; Takeuchi, K., 2001:
Transgenic rat model for renal tubule-specific transcription of thiazide-sensitive Na-Cl cotransporter gene

Zollmann, F.S.; Orzechowski, H.D.; Koehler, R.; Oksche, A.; Von Langsdorf, C.; Bader, M.; Paul, M., 2002:
Transgenic rat model of endothelin-B-receptor function in the vessel wall

Riess, O.; Nguyen, H.P.; Schmitt, I.; Holzmann, C.; Walther, T.; Bader, M.; Kask, A.; Vaarmann, A.; Schulz, J.B.; Higgins, D.; Bauer, A.; Li, X.J.; Von Hoersten, S., 2002:
Transgenic rat model of huntingtons disease

Davies, J.E.; Murphy, D., 2001:
Transgenic rat models of familial neurohypophysial diabetes insipidus

Tsuda, H.; Asamoto, M.; Toriyama, H.; Ochiya, T.; Sekiya, T., 2003:
Transgenic rat with human normal type c-Ha-ras gene

Goldsmith, M.A.; Speck, R.F.; Atchison, R.E.; Keppler, O., 2002:
Transgenic rats and rat cell lines expressing human CD4 and a human chemokine receptor

Chauveau, C.; Braudeau, C.; Menoret, S.; Tesson, L.; Guillot, C.; Usal, C.; Charreau, B.; Soulillou, J.P.; Cuturi, M.C.; Buelow, R.; Anegon, I., 2000:
Transgenic rats and recombinant adenovirus for in vivo analysis of HO-1 in transplant rejection and tolerance

Nagai, M.; Aoki, M.; Miyoshi, I.; Kato, M.; Pasinelli, P.; Kasai, N.; Brown, R.H.; Itoyama, Y., 2002:
Transgenic rats carrying human mutant copper-zinc superoxide dismutase genes with amyotrophic lateral sclerosis

Ketteler, M.; Liefeldt, L.; Westenfeld, R.; Gawlik, A.; Petermann, A.; Kossmehl, P.; Floege, J.; D.H.er, E.; Paul, M., 2002:
Transgenic rats for the human endothelin-2 gene develop progressive proteinuria and renal failure in anti-Thy11-glomerulonephritis

Ketteler, M.; Paul, M.; Liefeldt, L.; Koch, R.; D.H.er, E.; Distler, A., 1999:
Transgenic rats for the human endothelin-2-gene develop increased proteinuria and suppressed inducible NO-synthesis in anti-Thy1-nephritis

Mueller, O.J.seph; Rattunde, H.; Lange, M.; Lorenzen, H.P.ter; Degenhardt, M.; Franz, W.M., 2000:
Transgenic rats overexpressing SERCA2a compensate heart failure in aortic banding model

Arbatova, J.; Alhonen, L.; Kalda, A.; Korhonen, V.P.; Rasanen, T.L.; Jarvinen, A.; Sinervirta, R.; Zharkovsky, A.; Riekkinen, P.Sr; Lehesjoki, A.E.; Reeben, M., 1999:
Transgenic rats overexpressing cystatin B, human progressive myoclonus epilepsy gene, in the nervous system

Yoshimura, A.; Sugenoya, Y.; Inui, K.; Yamamura, H.; Watanabe, S.; Morita, H.; Ideura, T.; Takahashi, K., 1999:
Transgenic rats overexpressing human smooth muscle calponin diaplays suppressed mesangial cell proliferation and matrix expansion in anti-Thy 11 nephritis

Gobbi, M.; Moneta, D.; Ravizza, T.; Aliprandi, M.; Pirona, L.; Michalkiewicz, M.; Schwarzer, C.; Furtinger, S.; Sperk, G.; Vezzani, A., 2000:
Transgenic rats overexpressing neuropeptide Y are less susceptible to kainate-induced seizures and to kindling epileptogenesis

Frey, N.; Franz, W.M.; Degenhardt, M.; Lorenzen, H.P.ter; Katus, H.A., 1999:
Transgenic rats overexpressing wild-type human cardiac Troponin T show improved contractile performance in the working heart

Asamoto, M.; Hokaiwado, N.; Shirai, T., 2003:
Transgenic rats with decreased gap junctional intercellular communication in the liver are highly susceptible to hepatocarcinogenesis, but resistant to hepatic damage

Goley, M.; Gillaspy, G.; Oda, K.; Gruissem, W., 1999:
Transgenic reduction of inositol monophosphatase disrupts development of tomato

Selvaraj, G.; Nair, R.B.; Joy, R.W.I.; Keller, W.A.; Datla, R.S., 2002:
Transgenic reduction of sinapine in crucifera

Li, J.; Mclerie, M.; Lopatin, A., 2003:
Transgenic regulation of IK1 in the mouse heart strongly affects drug-induced arrhythmias

Dorsky, Richard, I., 2003:
Transgenic reporters and modulators of Wnt/beta-catenin signaling in the zebrafish CNS

Pravenec, M.; Landa, V.; Zidek, V.; Kren, V.; Kazdova, L.; Qi, N.; Wang, J.; S.L.zin, E.; Kurtz, T.W., 2000:
Transgenic rescue of defective Cd36 attenuates insulin resistance, dyslipidemia, and hypertension in spontaneously hypertensive rats

Okamoto, H.; Nakae, J.; Park, B.C.ul; Accili, D., 2001:
Transgenic rescue of insulin receptor knockout mice

Rubia, L.; D.P.lma, J.; Elliott, M.C.; Khush, G.S.; Bennett, J., 1999:
Transgenic rice plants containing an isopentenyl transferase gene driven by a senescence-specific promoter

Ha, S.B.; Lee, S.B.; Lee, D.E.; Guh, J.O.; Back, K., 2004:
Transgenic rice plants expressing Bacillus subtilis protoporphyrinogen oxidase gene show low herbicide oxyfluorfen resistance

Mclonlogue, L.C.; Zhao, J.; Sinha, S., 2001:
Transgenic rodent comprising APP-Swedish

Mclonlogue, L.; Zhao, J.; Sinha, S., 2003:
Transgenic rodents harboring APP allele having Swedish mutation

Blumwald, E.; Zhang, H.X.a, 2001:
Transgenic salt tolerant tomato plants overexpressing a vacuolar Na+/H+ antiport accumulate salt in the foliage but not in the fruits

Blumwald, E.; Zhang, H.X.a, 2001:
Transgenic salt tolerant tomato plants overexpressing a vacuolar Na/H antiport accumulate salt in the foliage but not the fruits

Yu, S.M.y; Shaw, J.F., 2004:
Transgenic seeds expressing amylopullulanase and uses therefor

Campbell, K.H.S., 2002:
Transgenic sheep from cultured cells

Felix, K.; Potter, M.; Janz, S., 2001:
Transgenic shuttle vector assays for assessing overall mutagenesis during normal and malignant cell development in vivo

Guasch, A.; Waqas, M.; Niaz, S.; Hsu, L.L., 2003:
Transgenic sickle cell mice develop a glomerular lesion similar to human sickle cell glomerulopathy

Tamura, Toshiki, 2000:
Transgenic silkworm Present situation and future

Haggman, H.; Piispanen, R.; Saranpaa, P.; Wen, Z.X.; Aronen, T.S., 2000:
Transgenic silver birch plantlets with pRiA4 T-DNA genes

Chung, D.H.; Dorfman, J.R.; Plaksin, D.; Belyakov, I.; Hunzinker, R.D.; Berzofsky, J.A.; Mage, M.G.; Natarajan, K.; Margulies, D.H., 1999:
Transgenic single chain beta2-m-H-2Dd molecules can educate CD8+ T cells but not NK cells

Hassanain, H.H.; Lopes, N.H.; Marialuisa, M.; Selvakumar, B.; Irshiad, F.I.; Ma, Q.; Sarkar, K.D.; Strauch, A.R.; Nuovo, G.J.; Morris, M.; Goldschmidt Clermont, P.J., 2000:
Transgenic smooth muscle cell expression of an activated Rac mutant induces hypertension

Noble, M.S.; Wheeler, M.B.; Hurley, W.L., 2001:
Transgenic sows overexpressing alpha-lactalbumin Piglet growth and milk component intake early in lactation

Yu, F.; Ding, L-Jun.; Sun, G-Bo.; Sun, P-Xiang.; He, X-Hong.; Ni, L-Gang.; Li, B-Chun., 2010:
Transgenic sperm produced by electrotransfection and allogeneic transplantation of chicken fetal spermatogonial stem cells

PoojaBhatnagar-Mathur; Rao,J.S.; VincentVadez; Sharma,K.K., 2010:
Transgenic strategies for improved drought tolerance in legumes of semi-arid tropics

Herbison, Allan, E., 2000:
Transgenic strategies to characterise GnRH neurones

Warkman, A.S.; Atkinson, B.G., 2001:
Transgenic studies into cardiac troponin I gene regulation during the postembryonic development of the amphibian tadpole

Marsh Armstrong, N.; Brown, D.D., 2000:
Transgenic studies of metamorphic changes in the nervous system of Xenopus laevis

Wells, S.; Murphy, D., 2003:
Transgenic studies on the regulation of the anterior pituitary gland function by the hypothalamus

Mannerloef, M.; Tenning, P.P.ter; Steen, P., 2003:
Transgenic sugar beet plant expressing cp4/epsps enzyme activity

Wagih, E.S.yed E.; Wagih, M.E., 2001:
Transgenic sugarcane regenerated from protoplasts expressing the gus reporter gene

Binsfeld, P.C., 2003:
Transgenic sunflower PEG-mediated gene transfer

Chiang, C.M.; Yeh, F.S.; Shaw, J.F.; Yu, S.M., 2003:
Transgenic sweet rice expressing a thermostable amylopullulanase in seeds leads to starch autohydrolysis and production of nutritionally-improved high-protein flour

Seebach, J.; Sachs, D.H.; Dersimonian, H.; Leguern, C., 2000:
Transgenic swine and swine cells having human HLA genes

Tu, C.F.; Lee, C.J.an; Lee, J.M.ng; Tsuji, K., 2003:
Transgenic swine having HLA-D gene, swine cells thereof and xenografts therefrom

Seebach, J.; Sachs, D.H.; Dersimonian, H.; Leguern, C., 2003:
Transgenic swine swine cells having human HLA genes

Rolo, A.; Skoglund, P.; Keller, R., 2001:
Transgenic technology and targeted gene expression in Xenopus laevis using the GAL4/UAS system

Walker, D.R.; Boerma, H.R.; All, J.N.; Parrott, W.A., 2002:
Transgenic technology for insect resistance Current achievements and future prospects

Wright, J.R.J.; Pohajdak, B., 2002:
Transgenic tilapia comprising a humanized insulin gene

Wright, J.R.Jr; Pohajdak, B., 2000:
Transgenic tilapia with a humanized insulin gene An inexpensive future source of donor islets for clinical islet xenotransplantation

Robson, C.A.; Ordog, S.H.; Vanlerberghe, G.C., 2001:
Transgenic tobacco cells lacking mitochondrial alternative oxidase have increased susceptibility to cell death-inducing stimuli

Pang, Y.Z.en; Yao, R.H.ng; Shen, G.A.; Qi, H.X.ong; Tan, F.; Sun, X.F.n; Tang, K.X.an, 2004:
Transgenic tobacco expressing Lycoris radiata agglutinin showed enhanced resistance to aphids

Lee Sun Hi; W.S.o Jin; Park, K.Y.ung, 1999:
Transgenic tobacco expressing sense and antisense genes of ACC synthase and ACC oxidase show altered levels of polyamines and ethylene

Semenyuk, E.G.; Orlova, I.V.; Stremovskii, O.A.; Balandin, T.G.; Nosov, A.M.; Bur'yanov, Y.I.; Deev, S.M., 2002:
Transgenic tobacco plants as producers of antiferritin scFv-antibody

Velazhahan, R.; Muthukrishnan, S., 2004:
Transgenic tobacco plants constitutively overexpressing a rice thaumatin-like protein show enhanced resistance to Alternaria alternata

Mitsuhara, I.; Shirasawa Seo, N.; Nakamura, S.; Iwai, T.; Honkura, R.; Ohashi, Y., 2001:
Transgenic tobacco plants introduced with luciferase gene as model plant for analysis of gene silencing

Trejo-Tellez,L.I.; Stenzel,R.; Gomez-Merino,F.C.; Schmitt,J.M., 2010:
Transgenic tobacco plants overexpressing pyruvate phosphate dikinase increase exudation of organic acids and decrease accumulation of aluminum in the roots

Arai, Yuko; Nakashita, Hideo; Kobayashi, Yumiko; Suzuki, Yoshikatsu; Doi, Yoshiharu; Yamaguchi, Isamu, 2001:
Transgenic tobacco producing co-polymer in peroxisomes

Fluhr, R.; Eshed, Y.; Ori, N.; Paran, I.; Zamir, D., 2000:
Transgenic tomato plants containing a fusarium resistance gene

Agharbaoui, Z.; Tabaeizadeh, Z., 1999:
Transgenic tomato plants expressing a L chilense drought induced chitinase gene; how do they behave under drought stress

Agharbaoui, Z.; Tabaeizadeh, Z., 2000:
Transgenic tomato plants expressing a Lycopersicon chilense drought-induced gene demonstrate enhanced tolerance to water stress

Cui, M.; Wang, Y.; Wisniewski, M.; Meilan, R.; Fuchigami, L., 2003:
Transgenic tomato that overexpresses SOD or APX exhibits enhanced tolerance to flooding stress

Dow, J.A.T.; Davies, S.A., 2000:
Transgenic tools for the analysis of cell-specific signalling pathways in an organotypic context

Kerr, M.; Davies, S.A.; Dow, J.A.T., 2000:
Transgenic tools for the dissection of second messenger signalling pathways in Drosophila

Powell, W.A.; Maynard, C.M., 2000:
Transgenic trees, hype or opportunity

Nelson, E.K.; Lee, L.; Harriman, R.; Turner, K.; Christoffer, P., 2003:
Transgenic turfgrasses and issues with gene flow

Grotewold, Erich, 2004:
Transgenic turfgrasses which signal exposure to chemicals and stress conditions

Arif, B.M.; Palli, S.R.ddy; Retnakaran, A.; Sohi, S.S., 1999:
Transgenic virus

Beacham, T.; Edlin, D.; Kille, P.; Harwood, J.L., 2002:
Transgenic wheat lines mimicking metabolic responses to the Greenhouse effect

Okano, T.; Ikeda, T.; Imazato, K.; Mano, H.; Fukada, Y., 2003:
Transgenic zebrafish expressing dominant negative mutant of zfBMAL in the pineal gland

Shafizadeh, E.; Huang, H.; Lin, S., 2002:
Transgenic zebrafish expressing green fluorescent protein

Goldman, D.; Li, Z.; Hankin, M.; Dai, X.; Ding, J., 1999:
Transgenic zebrafish identify 5 flanking DNA of the goldfish alpha1 tubulin gene that confers increased reporter gene expression in the developing and regenerating CNS

Ditullio, P.; Meade, H.; Cole, E.S., 2002:
Transgenically produced Antithrombin III

Meade, H.; Chen, L.H.w; Ditullio, P., 2003:
Transgenically produced non-secreted proteins

Echelard, Y.; Wilburn, B., 2001:
Transgenically produced prolactin

Prosser, H.; Bradley, A., 2003 :
Transgenics at breaking-point

Sang, H.M., 2004:
Transgenics, chickens and therapeutic proteins

Ramsey, W.J.; Blaese, R.M.chael; Xanthopoulos, K.G., 2001:
Transgenomic viruses

Hoang, O.K.m; Koerniati, S.; F.X.quin; Rajagopal, S.; Jefferson, R.A.; Kilian, A., 2001:
Transgenomics Novel technology for genomics and crop improvement

Messing, A.; Zhuo, L., 2002:
Transgentic mouse expressing green fluorescent protein in glial cells

Lambert, A.; Ekambaram, M.; Robinson, N.; Eckert, R., 1999:
Transgilutaminase reactivity of human involucrin

Kuramoto, N.; Matsuki, M.; Yamanishi, K.; Yasuno, H., 2000:
Transglutaminase 1 is essential to embryonic development of skin barrier

Haynes, L.W.; Smith, S.; Wilkinson, M.; Mahoney, S.A., 2000:
Transglutaminase C/type 2 regulates neurite stability and fascicle-formation in cerebellar granule neurons

Korponay Szabo, I.R.; Halttunen, T.; Laurila, K.; Sulkanen, S.; Lorincz, M.; B.Kovacs, J.; Maki, M., 2000:
Transglutaminase ELISA for IgA-deficient subjects

Lorand, L.; Waelsch, H.B., 2002:
Transglutaminase: remembering Heinrich Waelsch

Galli, F.; Benedetti, S.; Beninati, S.; Nicolini, L.; Lentini, A.; Canestrari, F.; Buoncristiani, U., 1999 :
Transglutaminase activation and polyaminated polymeric protein formation Evidences for a new class of uremic toxins

Kawashima, J.; Akiyama, M.; Hatanaka, K.; Takahashi, S.; Matsuo, I.; Shimizu, H., 2000:
Transglutaminase activity and cornified cell envelope formation in non-bullous congenital ichthyosiform erythroderma

Caccamo, D.; Forino, D.; Curro, M.; Ientile, R.; Ruggeri, P., 2003:
Transglutaminase activity in free-living amoebae

D.S.ndro, A.; Casali, S.; Serafini Fracassini, D., 2003:
Transglutaminase activity in programmed cell death The spermine role in preventing leaves of nutritional interest from degradation

Karpuj, M.V.; Steinman, L., 2000:
Transglutaminase aggregates huntingtin into non-amyloidogenic polymers and its enzymatic activity is increased in Huntingtons Disease brain nuclei

Aeschlimann, D.P.; Mosher, D.F., 2000:
Transglutaminase and gene encoding same

Meoro, A.; Chinchilla, V.; Sanchez, J.; Eleno, I.; Caselles, J.; Paya, A.; Boix, E.; Pico, A., 2001:
Transglutaminase autoantibodies are the best markers for celiac disease screening in Spanish type 1 diabetic children and adults

Zainelli, G.M.; Muma, N.A.; Ross, C.A.; Troncoso, J.C., 2001:
Transglutaminase catalyzed cross-links in intranuclear inclusions in HD brain

Zainelli, G.M.; Ross, C.A.; Troncoso, J.C.; Muma, N.A., 2000:
Transglutaminase catalyzed cross-links in intranuclear inclusions in Huntingtons disease brain

Mandrusiak, L.M.; Beitel, L.K.; E.H.ji, Y.A.; Scanlon, T.C.; Alvarado, C.; Gottlieb, B.; Trifiro, M.A., 2002:
Transglutaminase cross-linking of androgen receptor could inhibit the proteasome Possible pathogenic implications for spinobulbar muscular atrophy

Zainelli, G.M.; Singer, S.; Norlund, M.; Muma, N.A., 2000:
Transglutaminase cross-links tau in vitro and in AD

Taylor, M.M.; Brown, E.M., 2001:
Transglutaminase crosslinking of gelatins

Zemaitaitis, M.O.; Kim, S.Y.; Lee, J.M.; Muma, N.A., 2001:
Transglutaminase enzyme activity and expression of transglutaminase 1 is increased in progressive supranuclear palsy

Biagi, F.; Bassi, E.; Ardigo, M.; Vignini, M.A.; Caravaggi, M.; Borroni, G.; Corazza, G.R., 2000:
Transglutaminase expression in dermatitis herpetiformis

Sarnelli, G.; Cosenza, V.; Gentile, F.; Rocco, A.; Cuomo, R., 2003:
Transglutaminase expression in myenteric plexus of rat with tnbs induced colitis

Bech, L.; Rasmussen, G.; Halkier, T.; Okada, M.; Andersen, L.N.nboe; Kauppinen, M.S.kari; Sandal, T., 2002:
Transglutaminase from oomycetes

Lin, Y.S.in; Liu, C.H.iesh; Chu, W.S.en, 2003:
Transglutaminase gene of Streptoverticillium ladakanum and the transglutaminase encoded therefrom

Adini, A.; Ginsburg, H.; Krugliak, M.; Li, L.; Warburg, A., 1999:
Transglutaminase in Plasmodium parasites

Von Horsten, H.H.; Pena, A.; Whelly, S.; Phelps, B.; Cormier, N.; Cornwall, G.A., 2004:
Transglutaminase mediates cross-linking of CRES protein

Beams, Z.K.; Lloyd Still, J.D.; Sandler, R.; Mcconnie, R.; Jakate, S., 2003:
Transglutaminase not foolproof in diagnosis of Celiac Disease in children

Mandrusiak, L.M.; Beitel, L.K.; Wang, X.; Scanlon, T.C.; Chevalier-Larsen, E.; Merry, D.E.; Trifiro, M.A., 2003:
Transglutaminase potentiates ligand-dependent proteasome dysfunction induced by polyglutamine-expanded androgen receptor

Lentini, A.; Beninati, S., 1999:
Transglutaminase-catalyzed spermidine incorporation into fibronectin and laminin reduces the in vitro metastatic behaviour of B15-F10 melanoma cells

Lambert, A.; Robinson, N.; Eckert, R., 1999:
Transglutaminase-dependent covalent modification of S100 proteins

Zainelli, G.M.; Norlund, M.A.; Muma, N.A., 1999:
Transglutaminase-induced crosslinks in human tau proteins in vitro and in Alzheimers disease

Cooper, A.J.L.; Gentile, V.; Sepe, C.; Blass, J.P., 2000:
Transglutaminases A possible role in n/Qn-expansion diseases and selective vulnerability?

Gentile, V.; Cooper, A.J.L., 2004:
Transglutaminases - possible drug targets in human diseases

D'argenio, G.; Della Valle, N.; D.M.tteo, G.; Cosenza, V.; Giogio, P.; Margarucci, S.; Petillo, O.; Jori, F.; Mazzacca, G.; Peluso, G., 2002:
Transglutaminases and colonic mucosal repair in patients with ulcerative colitis

Kim, S.Y.; Browne, S.E.; Cooper, A.J.L.; Blass, J.P., 2002:
Transglutaminases in Huntington brain Possible relation to selective vulnerability

Ientile, R.; Caccamo, D.; Catania, M.A.; Curro, M.; Marciano, M.C.; Calapai, G., 2003:
Transglutaminases in cerebral ischemia

Steinert, P.M.; Marekov, L.; Raghunath, M.; Traupe, H.; Boeshans, K.; Ahvazi, B., 2002:
Transglutaminases under pressure

Taira, T.; Fujiwara, M.; Dennhart, N.; Hayashi, H.; Onaga, S.; Ohnuma, T.; Letzel, T.; Sakuda, S.; Fukamizo, T., 2010:
Transglycosylation reaction catalyzed by a class V chitinase from cycad, Cycas revoluta: a study involving site-directed mutagenesis, HPLC, and real-time ESI-MS

Wong, C H.; Kimura, T., 1999:
Transglycosylation reactions employing beta-galactosidase

Hennies, H.C.; Lestringant, G.G.; Frossard, P.M.; Eckl, K.M.; Reis, A., 2001:
Transgressive palmoplantar keratoderma; evidence for genetic and clinical heterogeneity

Stoilova, Ana, 2002:
Transgressive variability in cotton hybrids

Warnken, U.H.; Forster, H., 2002:
Transhalogenation of Sevoflurane Catalysed by Dry Amsorb

Rizzo, V.; Montalbetti, L.; Moratti, R., 1999:
Transhemispheric diaschisis in a rat model of focal cerebral ischemia Biochemical investigation

Sharif, K.; de Ville de Goyet, J.; Beath, S.V.; Protheroe, S.; John, P., 2002:
Transhepatic hickman line placement: improving line stability by surgically assisted radiologic placement

Theodoraki, K.; Prachalias, A.; Wendon, J.; Rela, M.; Potter, D.; Papadamitriou, L.; Papadamitriou, J.; Heaton, N., 1999 :
Transhepatic lactate flux in an experimental model of acute liver injury

Mohamed, H.H.; Jalan, R.; Damink, S.O.de; Hogaboam, C.M.; Lukacs, N.W.; Bone Larson, C.L.; Hayes, P.C.; Collitti, L.M.; Strieter, R.M.; Kunkel, S.L.; Simpson, K.J., 2001:
Transhepatic neutrophil chemotaxis and chemokine concentrations in patients with chronic liver disease

Richardson, W.S.; Oza, M.; Smith, J.W.; Bolton, J.S., 2000:
Transhiatal esophagectomy Can we lower the stricture rate?

Loukanov, T.; Dimitrov, V.; Djongov, L., 1999:
Transhiatal oesophagectomy in the treatment of carcinoma of the lower oesophagus and cardia of the stomach - Influence of preoperative risk factors

Fernandez Rivera, S.; Salla, A.; Hiernaux, P.; Williams, T., 2003:
Transhumance and dry-season supplementation for cattle in the Sahel

Fioravanti, C.F.; Vandock, K.P., 2010:
Transhydrogenase and the anaerobic mitochondrial metabolism of adult Hymenolepis diminuta

Cooper, N.; Stasi, R.; Feuerstein, M.; Bussel, J.B., 2002:
Transient B Cell Depletion with Rituximab, an Anti CD20 Monoclonal Antibody, Resulted in Lasting Complete Responses in 16 of 57 Adults with Refractory Immune Thrombocytopenic Purpura

Shy, M.E.; Krajewski, K.M.; Garbern, J.Y.; Hoban, T.F.; Lewis, R.A.; Kamholz, J.; Fishbeck, K.H.; Paulson, H.L., 2002:
Transient CNS white matter abnormality in X-linked Charcot-Marie-Tooth Disease

Jilani, I.; O'brien, S.; Manshouri, T.; Thomas, D.A.; Thomazy, V.A.; Imam, M.; Naeem, S.; Verstovsek, S.; Kantarjian, H.; Giles, F.; Keating, M.; Albitar, M., 2002:
Transient Downmodulation of CD20 by Rituximab

Van Der Est, A.; Brown, S., 2001 :
Transient EPR studies of electron transfer in photosystem I containing non-native quinones

Bagi, Z.; Koller, A.; Kaley, G., 2004:
Transient Elevation of Glucose Concentration Reduces NO-Mediation of Flow-Induced Arteriolar Dilation due to Interaction between Superoxide and tetrahydrobiopterin

Rosales, C.M.; Jones, D.; Medeiros, L.J.; Manning, J.T.; Keating, M.J.; Abruzzo, L.V., 2001:
Transient Epstein-Barr virus positive large B-cell lymphoproliferative disorders arising in patients with low-grade B-cell lymphoma

Mana, F.; Laubach, M.; Reynaert, H.; Urbain, D., 2004:
"Transient HELLP syndrome" followed by massive ascites

Handzel, Z.T.; Kidon, M.; Stein, M., 2000:
Transient Hypogammaglobulinemia of Infancy Frequent and presenting as recurrent infections and atopy

Geller, P.; Guerra, C.V.ronica; Grecco, O.; Kalil, J.E.ias; Barros, M.T.ledo, 2001:
Transient IgA-deficiency in adulthood and chronic hepatitis C Cause or effect?

Lyons, A.; Krause, D.; Leahy, M.; O'connor, R., 2001:
Transient Jun N-terminal kinase activation and suppression of apoptosis by IGF-I

Watanabe, S.; Johnston, D., 2000:
Transient K+ channel contribution to the induction of LTP in dendrites of hippocampal CA1 pyramidal neurons

Furuyama, H.; Iwado, Y.; Yoshinaga, K.; Mabuchi, M.; Ito, Y.; Noriyasu, K.; Tamaki, N., 2001:
Transient LV dysfunction in ischemic myocardium due to post-exercise stunning not subendocardial hypoperfusion Comparative study with exercise and pharmacological stress gated myocardial spect

Sastry, S.; Barnoski, B.; Sandoval, C.; Weinstein, M., 2002 :
Transient MPD in a newborn A case report

Zipursky, A.; Brown, E.J.; Christensen, H.; Doyle, J., 1999:
Transient Myeloproliferative disorder and hematologic manifestations of Down syndrome

Tremblay, R.G.; Durkin, J.; Chakravarthy, B.; Callaghan, D.; Rashid, A., 2001:
Transient NMDA receptor inactivation by MK-801 preconditions cultured cortical neurons through multiple signaling pathways

Robinson, D.O.; Cave, H.; Mackay, D.; Coupe, A.; Shield, J.; Polak, M.; Temple, I., 2001:
Transient Neonatal Diabetes Mellitus, the spectrum of mutations in a cohort of 67 patients

Temple, I.K.; Mackay, D.J.G.; Coupe, A.M.; Cave, H.; Polak, M.; Siebert, R.; Barber, J.C.K.; Robinson, D.O.; Shield, J.P.H., 2001:
Transient Neonatal Diabetes The 6q24 phenotype

Hardy, R.G.; Sanders, D.S.A.; Morton, D.G.; Matthews, G.M.; Adams, C.; Pretlow, T.P.; Jankowski, J.A.Z., 1999:
Transient P-Cadherin expression is important in the early stages of exophytic growth and clonal expansion within the colon

Phillips, J.W.lliam; Barringhaus, K.G.; Hesselbacher, S.E.; Manka, D.R.; Sanders, J.M.; Normansell, D.E.; Ley, K.F.; Sarembock, I.J., 2000:
Transient P-selectin blockade reduces neointima formation after arterial injury in apolipoprotein-E deficient mice

Earley, S.; Waldron, B.J.; Patlak, J.; Brayden, J.E., 2004:
Transient Receptor Potential Channel TRPM4 Contributes to Myogenic Vasoconstriction of Cerebral Arteries

Ianzini, F.; Duffie, T.; Kosmacek, E.A.; Mackey, M.A., 2002:
Transient S/G2 delay in Adriamycin-treated PC-3 human prostate cancer cells is followed by overaccumulation of cyclin B1 protein and induction of mitotic catastrophe

Kumar, P.D.leep; Sandhu, S.S., 2000:
Transient SIADH occurring after total hip replacement

Riskin, A.; Abend Weinger, M.; Riskin Mashiah, S.; Kugelman, A.; Bader, D., 2002:
Transient Tachypnea of the Newborn Characteristics and risk factors

Mizuguchi, Y.; Tsuchimoto, Y.; Fagiolini, M.; Hensch, T.K., 2001:
Transient TrkB blockade impairs maturation of parvalbumin-positive interneurons in visual cortex

Brewer, L.M.; Kuck, K.; Orr, J.A., 2003:
Transient Ventilation Changes Can Replace Rebreathing in Partial Fick Cardiac Output Measurements

Byrdin, M.; Eker, A.P.M.; Vos, M.H.; Brettel, K., 2003:
Transient absorption spectroscopy of the excited flavin radical in DNA photolyase from E coli

Redmond, R.W.; Aveline, B.M., 1999:
Transient absorption spectroscopy used to study mechanisms of sensitized cellular phototoxicity

Dobek, A.; Gibasiewicz, K.; Naskrecki, R.; Lorenc, M.; Ziolek, M.; Kubicki, J.; Karolczak, J.; Goc, J.; Miyake, J., 2001:
Transient absorption studies of the reaction center of the photosynthetic bacterium Rb sphaeroides R-26 in the blue spectral range

Wereszczynska, N.; Naskrecki, R.; Ziolek, M.; Dobek, A., 2003:
Transient absortion studies of the Rb sphaeroides R-26 reaction center in the blue spectral

Dammerman, R.S.; Kriegstein, A.R., 2000:
Transient actions of neurotransmitters during neocortical development

Mockridge, J.W.; Punn, A.; Sudgen, P.H.; Latchman, D.S.; Heads, R.J., 1999:
Transient activation of MAP kinases during mild simulated ischemic preconditioning does not confer delayed protection in cardiomyocytes

Dana, A.; Jonassen, A.K.; Yellon, D.M., 1999:
Transient activation of adenosine A1 receptors induces delayed cardioprotection in rats Role of Mn-superoxide dismutase

Merlin, Lisa, R., 1999:
Transient activation of group I mGluRs during iGluR block induces potentiated epileptiform discharges

Baghai, M.; Anderson, D.R.; Austin, C.B.; Jennings, J.M.; Mukaida, M.; Hosseinpour, R.; Shattock, M.J., 2003:
Transient activation of mitochondrial Kca channels protects the human myocardium via a free radical-dependent mechanism

Kats, E.S.; O'brien, L.E.in; Hansen, S.H.nning; Mostov, K.E., 2000:
Transient activation of the Raf-MEK-ERK pathway mimics HGF-induced tubulogenesis in MDCK cysts

Kefalov, V.J.; Crouch, R.C.; Cornwall, M.C., 1999:
Transient activation of transduction by 11-cis retinal during pigment regeneration in bleach-adapted rods

Ohbayashi, M.; Ohki, K.; Miyashita, Y., 2001:
Transient activities related to linkage of sensory information and saccade preparation in the monkey frontal cortex

Dana, A.; Jonassen, A.K.; Yellon, D.M., 1999:
Transient adenosine A1 receptor activation induces delayed cardioprotection in rats Role of Mn-superoxide dismutase

Parker, L.; Moran, E.; Wu, S-Yung., 2002:
Transient adrenal gland uptake of gallium during septicemia

Meacham, L.R.mine; Mazewski, C.; Krawiecki, N., 2002:
Transient adrenal insufficiency with Megace treatment of cachexia in pediatric brain tumor patients

Guichelaar, M.M.J.; Leenen, L.P.H.; Braams, R., 2004:
Transient adrenocortical insufficiency following traumatic bilateral adrenal hemorrhage

Shiramizu, K.M.; Okada, A.A.; Hirakata, A., 2001:
Transient amaurosis associated with intraocular gas during ascending high-speed train travel

Wang,J.W.; Hu,Y.; Li,J.S., 2010:
Transient analysis to design buffer capacity in dairy filling and packing production lines

Daniel, T.L.; Goldman, E.B.; Combes, S.A., 1999:
Transient and intermittent phenomena in aquatic locomotion

Kohn, A.; Metz, C.; Tommerdahl, M.; Whitsel, B.L., 2000:
Transient and opposite modulation of layer II/III and I inputs to neocortical pyramidal cells

Lopez Garcia, M.J.; Gastaldo Simeon, E.; Palau, F.; Alpera, R., 2000:
Transient and permanent neonatal diabetes

Shoemaker, L.R.; Schurman, S.J., 2003:
Transient and pronounced phosphaturia in hypercalcemic Williams syndrome

Evans, R.W.; Jacobson, D.M., 2003:
Transient anisocoria in a migraineur

Dautzenberg, M.D.minique; Amiral, J.; Sannier, N.; Blanche, S., 2000:
Transient anti-II antibodies and strong lupus anticoagulant activity in two children Relation to infectious disease or LED

Garcia, H.H.; Gonzalez, A.E.; Gilman, R.H.; Palacios, L.G.; Jimenez, I.; Rodriguez, S.; Wilkins, P.; Tsang, V.C.W., 2000:
Transient antibody response in Taenia solium infection in field conditions A major contributor to high seroprevalence

Tomaszewski, M.; Zukowska-Szczechowska, E.; Zywiec, J.; Grzeszczak, W., 2001:
Transient anuria in a patient with chronic renal failure and liver affection after a single oral dose of diclofenac

Kaga, T.; Fonseca, R.A.; Dantas, M.A.; Spaide, R.F., 2001:
Transient appearance of classic choroidal neovascularization after transpupillary thermotherapy for occult choroidal neovascularization

Hellier, J.L.; Staley, K.J., 2002:
Transient application of NMDA antagonists produces a persistent reduction in seizure activity

Ulfman, L.H.; Van Der Linden, J.A.M.; Joosten, D.P.H.; Zwaginga, J.J.; Lammers, J.J.W.; Koenderman, L., 2000:
Transient arrest of rolling leukocytes A novel way to regulate extravasation

Seghaye, M.C.; Kong, X.; Grabitz, R.G.; Hoevels Guerich, H.H.; Buding, B.; Vazquez Jimenez, J.F.; Messmer, B.J.; Von Bernuth, G., 2001:
Transient arrhythmias after cardiac surgery in neonates and children

Sugie, K.; Kakehi, Y.; Ogawa, M., 2004:
Transient arterial hyperintensity on fast fluid-attenuated inversion recovery images in hyperacute cardiogenic cerebral embolism

Shibata, M.; Sakai, E.; Kato, Y.; Yamamoto, K.; Sakai, H., 2000:
Transient association and processing of alpha2-macroglobulin at a novel site by cathepsin E

Walker, M.IIi; Harrison Bernard, L.M.; Cook, A.K.; Navar, L.G., 1999:
Transient autoregulatory responses of afferent arteriolar diameter in juxtamedullary nephrons

Banas, M.D.nald; Suzuki, G.; Canty, J.M.J.; Fallavollita, J.A., 2003:
Transient beta-adrenergic stimulation elicits greater contractile reserve than a graded protocol in chronically stunned myocardium

Okauchi, M.; Mizukami, Y., 1999:
Transient beta-glucuronidase gene expression under control of CaMV 35S promoter in Porphyra tenera

Amin, S.B.; Charafeddine, L.; Guillet, R., 1999:
Transient bilirubin encephalopathy can manifest as Apnea of Prematurity

Ziller, C.; Stoeckel, F.; Boon, L.; Haegel Kronenberger, H., 2002:
Transient blocking of both B71 and B72 in addition to CD40-CD40L interaction fully abrogates the immune response following systemic injection of adenovirus vector

Borlongan, C.V.; Emerich, D.F.; Hoffer, B.J.; Bartus, R.T., 2000:
Transient blood-brain barrier opening via the intravenous injection of bradykinin receptor agonist, cereport, facilitates low dose cyclosporine-A-induced protection against 6-hydroxydopamine neurotoxicity

Vivino, L.L.; Tusa, R.J., 1999:
Transient central positional vertigo and nystagmus from migraine

Benseler, S.M.; Silverman, E.D.; Tsang, L.M.; Tyrrell, P.N.; Aviv, R.I.; Armstrong, D.; Schneider, R.; Feldman, B.M.; Laxer, R.M.; Deveber, G., 2003:
Transient cerebral arteriopathy and primary angiitis of the central nervous system in children A spectrum of cerebral arterial disease?

Rameshwar, P.; Gascon, P.; Murthy, R.G.; Bandari, P.S., 2002:
Transient change in the function of breast cancer cells from epithelial to mesenchymal type responses after contact with bone marrow stroma

Curtis, T.M.; Scholfield, C.N.rman, 1999:
Transient chloride currents induced by endothelin-1 in microvascular smooth muscle of the rabbit choroid

Evans, C.L.; Henderson, M.J.; Smith, M.; Cleary, M.A.; Mcclean, P., 2000:
Transient citrullinaemia associated with generalised liver disease